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1. General Introduction 
The human brain is the most fascinating and complex organ that we know. A conservative 
estimate of the number of neurons in the brain is 80 billion, more than 10 times the population 
of the world; the number of possible connections among those neurons is at least 100 trillion, 
many thousands of times the number of stars in our galaxy. It controls all functions of the body, 
interprets information from the outside world, and embodies the essence of the mind and soul. 
Intelligence, creativity, emotion, and memory are a few of the many things governed by the 
brain. 
Not very long time ago, the feasibility of mapping the distinguishable regions of the human 
brain in relation to their functional roles seemed remote. With the tremendous advances in 
neuroscience and neurotechnologies undertaken over the past two decades, however, the 
opportunity now exists. This allows to approach experimental, computational and theoretical 
studies to gain an integrated understanding of the brain structure and its functioning, as 
necessary to clarify the neurobiological basis of human thought and emotion and to discern 
mechanisms that underlie sensory perception and locomotor functions. Indeed, many of the 
intricate anatomical connections of the brain are being defined in great detail. New capabilities 
have emerged to identify and describe the biochemical, molecular, and genetic mechanisms that 
determine brain structure and functions, and the overall activity of the human brain during 
mental activity can be measured and visualized. Using new generations of implantable silicon 
probes, it is even becoming possible to monitor simultaneously the activity of many neurons 
within complex neural networks during discrete behaviors.  
Although all these progresses, our current understanding of the brain is still primitive and 
discovering its secrets continues to be a challenging goal in neuroscience. Given the complexity 
of signaling and interactions occurring in the brain at multiple scales, advances in neuroscience 
is intimately related to advances in neurotechnologies capable of monitoring and manipulating 
such a signaling diversity across scales, ranging from nanometers (biomolecules) to centimeters 
(entire organisms), but also to the availability of relevant models of brain circuits. The 
development of biological models enabling to dig into the fine details of the cellular complexity 
of the brain, inaccessible in human subjects, is crucial for gaining a better understanding of 
brain functions, of its development and of human brain diseases. In particular, as we know, the 
brain is not only composed by neurons. Neurons remain the major subject of study for 
neuroscience, but research on glia cells and neuro-glia interactions has radically increased over 
the last twenty years. Neurons and glia in the brain exchange (bio)chemical, electrical, and 
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mechanical cues. This symphony of signals originates at the nanoscale, where molecular 
machinery coordinates chemical reactions and conformation changes, e.g., ion channel opening. 
Combined, these events govern cellular function at the microscale, such as for tuning action 
potential firing. Coordination at the microscale then translates into the emergence of macroscale 
neural circuits, which drive behavior.  
Driven by with my deep interest in the neurobiology of neuro-glia interactions, and motivation 
to contribute in advancing our current understandings of neurobiological processes in health 
and disease, in this PhD thesis I focused on the opportunity to study that apply new 
microtechnology platforms for investigating neurobiological questions in in vitro neuronal 
models. In particular, my work focused on two major projects that are reported in this thesis. 
While in the first I focused on the use of a more conventional technology (i.e. microfluidics) to 
dig into specific neurobiological questions, in the second I contributed to the development of a 
radically new technology to interface brain organoids that is currently under study at IIT.  
In the first project, I focused on a microfluidic device that allows me to experimentally 
investigate the synchronization process of clock genes among distant neuronal populations 
through neuro-glia interactions. As it will be described, the in vitro approach that I developed 
allowed me to dissect different signaling channels that cannot be easily addressed in vivo due 
to the high cellular density and connectivity complexity of the brain.   
In the second project, I investigated the effects of surface functionalization of silicon (Si) 
microchips (100 x 100 x 50 µm3) in driving their three-dimensional (3D) assembling with 
cortical cells and in spatially tuning their 3D incorporation inside neurospheroids. This work is 
part of a larger project of my laboratory aimed at developing a new generation of “bionic 
organoids” with built-in wireless transducers that may enable to advance in the exploitation of 
brain organoids as model systems of the human brain for dissecting cellular and molecular 
mechanisms of human brain diseases and for the identification and study of therapeutic 








2. Lab-on-a-chip investigation of molecular clock 




In mammals, the suprachiasmatic nucleus (SCN) of the hypothalamus is considered the master 
circadian pacemaker which coordinates circadian rhythms in the central nervous system (CNS) 
and across the entire body. The SCN receives light input from the eyes through the 
retinohypothalamic tract and then it synchronizes other clocks in the CNS and periphery, thus 
orchestrating rhythms throughout the body. However, little is known about how so many 
cellular clocks within and across brain circuits can be effectively synchronized to entrain the 
coordinated expression of clock genes in cells distributed all over the brain.  
In this work I investigated the possible implication of two possible pathways: i) paracrine 
factors-mediated synchronization and ii) astrocytes-mediated synchronization. To study these 
pathways, I adopted an in vitro research model that I developed based on a lab-on-a-chip 
microfluidic device designed and realized in our laboratory. This device allows growing and 
compartmentalizing distinct neural populations connected through a network of astrocytes or 
through a cell-free channel in which the diffusion of paracrine factors is allowed. By taking 
advantage of this device, upon its validation, I synchronized neural clocks in one compartment 
and analyzed, in different experimental conditions, the induced expression of clock genes in a 
distant neural network grown in the second compartment.  
Results show that both pathways can be involved, but might have different roles. Neurons 
release factors that can diffuse to synchronize a neuronal population. The same factors can also 
synchronize astrocytes that, in turn, can transmit astrocyte-mediated molecular clocks to more 
distant neuronal populations. This is supported by experimental data obtained using 
microfluidic devices featuring different channel lengths. I found that paracrine factors-mediated 
synchronization occurs only in the case of a short distance between neuronal populations. On 
the contrary, interconnecting astrocytes define an active channel that can transfer molecular 
clocks to neural populations also at long distances. The study of possibly involved signaling 
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factors indicate that paracrine factors-mediated synchronization occurs through GABA 
signaling, while astrocytes-mediated synchronization involves both GABA and glutamate. 
These findings strength the importance of the synergic regulation of clock genes among neurons 
and astrocytes, and identify a previously unknown role of astrocytes as active cells in 
distributing signals to regulate the expression of clock genes in the brain. Preliminary results 
also show a correlation between astrocyte reactivity and local alterations in neuronal 
synchronization, thus opening a new scenario for future studies in which disease-induced 






















A key feature of life on Earth is its capacity to adapt to the environment. Different geographical 
locations have different environments and thus organisms adapt to the conditions that are 
prevalent at their location to enhance their survival. However, at any given location, profound 
changes in environmental light and temperature occur daily because of the rotation of the Earth 
on its axis. To adapt to such changes, most organisms have evolved an internal biological clock 
that anticipates day/night cycles and helps them to optimize their physiology and behavior 
(Young and Kay, 2001) (Figure 1). This internally generated day-night rhythm is known as 
“circadian rhythm” and has a period of approximately 24 h (Dunlap et al., 2004), thus the name 
circadian, from the Latin words “circa” (about) and “dies” (day), coined by Franz Halberg in 
1959.  
Circadian rhythms are ancient and conserved throughout evolution. They are known to exist in 
life forms from unicellular cyanobacteria and protozoans to all multicellular organisms, 
including fungi, plants, insects, rodents and humans (Dunlap, 1999). Driven by cellular ‘clocks’ 
distributed across the body, these rhythms adjust us to the world by preparing the brain, as well 
as other tissues and organs, to perform very different, often incompatible, functions appropriate 
to the anticipated day or the anticipated night. For example, in diurnal species, such as humans, 
neural mechanisms that maintain attention and cognitive capacity are upregulated in daytime, 
whereas preparation for night involves the activation of pathways that are essential for sleep-
dependent memory consolidation (and reconsolidation) and synaptic scaling. On the contrary, 
nocturnally active species, such as mice, exhibit equally robust daily changes, but they are 
oppositely phased to light and dark cycles (Hastings et al., 2018). Furthermore, circadian 
rhythms regulate a large number of physiological and behavioral functions, such as hormone 
secretion, body temperature, metabolism and immune responses (Stratmann and Schibler, 
2006). Therefore, it is not surprising that disruption of the circadian clock is associated with 
several pathogenesis, such as obesity, cardiovascular diseases, sleep disorder, depression, 
cognitive function, memory formation, some neurological diseases and even cancer (Gerstner 




Figure 1: Circadian rhythms in mammals. Mammals biological clock anticipates and adapts 
physiological and behavioral functions to the different phases of the day. This figure was adopted from 
The Nobel Committee for Physiology or Medicine.  
Observations that organisms adapt their physiology and behavior to the time of the day in a 
circadian fashion have been documented for a long time and are commonly agreed to have 
begun with the observation of leaf and flower movements in plants (McClung, 2006). In 1729, 
the French astronomer Jean Jacques d’Ortous de Mairan noticed that leaves of a heliotrope plant 
moved rhythmically throughout the day (de Mairan, 1729). To test if this movement was 
independent of diurnal signals, Jean Jacques d’Ortous de Mairan  moved the plants to a dark 
cellar and observed that, even in the absence of light cues, the leaf movement persisted. This 
observation suggested an endogenous origin of the daily rhythm. Following this first 
experiment, a number of scientists repeated and expanded these observations through the 19th 
and early 20th centuries, in each case exploiting plant leaf movements.  
Animal circadian rhythms were not scientifically described until much later, with pigment 
rhythms in arthropods (Kiesel, 1894) and daily activity in rats (Richter, 1922) being among the 
first reported in the literature. Nowadays, in mammals the circadian system is considered to be 
organized in a hierarchy of multiple oscillators at organism and cellular level. At organism 
level, the suprachiasmatic nucleus (SCN) of the hypothalamus is the central pacemaker at the 
top of the hierarchy. At cellular level, the circadian clock consists in the transcription- and 
translation-based interconnected feedback loops, in which the transcription factors BMAL1 and 
CLOCK drive the expression of Per and Cry genes, whose products lead to the inhibition of 
their own transcription (Dunlap, 1999). This process oscillates with a 24 h period, producing 
the ‘ticking’ of the biological clock. 
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2.2.1 Circadian timekeeping at molecular level 
A series of biochemical and genetic approaches made it possible to define the core 
transcriptional components of the oscillatory mechanism. The discoveries of such molecular 
mechanisms are due to Jeffrey C. Hall, Michael Rosbash and Michael W. Young, winners of 
the 2017 Nobel Prize in Physiology or Medicine (Callaway and Ledford, 2017).  
The recurrent motif of the oscillatory mechanism is one in which positive transcription factors 
drive the expression of genes encoding negative factors that, following a suitable delay, inhibit 
the initial activation. This closure of the negative feedback loop completes the first half of the 
circadian cycle, whilst the second half involves the progressive degradation of the negative 
factors to facilitate the re-initiation of a new transcriptional phase. Thus, the molecular basis to 
the oscillation can be viewed as a transcriptional/post-translational feedback loop (TTFL) 
(Hastings et al., 2019) as it is schematically illustrated in Figure 2. 
The mammalian oscillator has clearly taken its cues from its position in the evolutionary tree; 
it is gratifyingly similar to its closet well-studied relatives, the insects, and contains aspects of 
logic and protein structure clearly conserved in fungi and perhaps beyond (Dunlap, 1999). The 
positive factors are Circadian Locomoter Output Cycles Protein Kaput (CLOCK) and Brain and 
muscle ARNT-like 1 (BMAL1, also known as ARNTL), which are basic helix-loop-helix 
transcription factors that heterodimerise via so-called PAS domains to bind DNA at Enhancer 
boxes (E-boxes) and thereby drive transcription. The negative factors are Period (PER1, PER2) 
and Cryptochromes (CRY1, CRY2) (Takahashi et al., 2017). All these genes involved in the 
TTFL are commonly named “clock genes”. 
Briefly, beginning at Circadian Time (CT) 0, heterodimers of CLOCK and BMAL1 drive the 
expression of PER and CRY proteins. By the end of the circadian day (CT12), PER–CRY 
complexes have accumulated in the nucleus and start to repress their own expression. Therefore, 
over the course of the ensuing circadian night (CT12–CT24 (CT0)), PER and CRY mRNA 
levels fall and the existing PER–CRY complexes are degraded. This degradation allows the 
cycle to reinitiate approximately 24 solar hours after the previous transcriptional initiation 
(Hastings et al., 2018). The cycle is stabilized by accessory loops in which CLOCK and 
BMAL1 drive E-box-mediated circadian expression of the nuclear receptors RORα, REV-
ERBα (also known as NR1D1) and REV-ERBβ (also known as NR1D2), which in turn act via 
REV response element (RRE) sequences to activate and suppress BMAL1 transcription, 
respectively (Preitner et al., 2002; Cho et al., 2012). 
The time cues defined by the changing molecular status of these interlocked feedback loops are 
transmitted to the rest of the cell to coordinate its activities. Indeed, a large number of circadian 
8 
 
transcription factors not only regulate their own transcription, but also the expression of 
numerous other “clock-controlled genes” (CCGs) (Dunlap, 1999) whose protein products are 
not essential for the core clock mechanism itself. Among these CCGs there are genes regulating 
various enzymes, like phosphoenolpyruvate carboxykinase, glycogen phosphoylase, and 
glucose-6-phosphatase (Panda et al., 2002); various voltage-gated calcium and potassium 
channels (Ko et al., 2009); peptides, such as Arginine-Vasopressin (AVP; Jin et al., 1999) and 
albumin site D-Binding Protein (DBP; Lopez-Molina et al., 1996). 
 
Figure 2: The molecular circadian clock in mammalian cells. The molecular mechanisms of 
circadian rhythms can be illustrated by the transcription of the Period (Per1 and Per2) and 
Cryptochrome (Cry1 and Cry2) genes that are activated by heteromeric complexes containing CLOCK 
and BMAL1 proteins that act through the E-box regulatory sequences of their target genes. In turn, PER 
and CRY proteins inhibit BMAL1–CLOCK activity, and therefore, their own transcription. This core 
oscillation is augmented and stabilized by a secondary loop involving two orphan nuclear receptor 
proteins, REV-ERBα and RORα, which affect Bmal1 expression. Importantly, the CLOCK–BMAL1 
heterodimer regulates the transcription of many CCGs, which in turn influence a wide array of 
physiological functions external to the oscillatory mechanism. This figure was adopted from Golombek 
et al., 2014.  
2.2.2 Circadian timekeeping at the organism level: the suprachiasmatic 
nucleus 
Mammals circadian system is a body-wide hierarchy of interlocked circadian oscillators present 
in cells of major organs. For proper functioning of the circadian timing system, all the circadian 
clocks in the body must be kept synchronized with one another and to the 24 h day. This is the 
function of the suprachiasmatic nucleus (SCN) of the hypothalamus, the master circadian 
pacemaker (Klein et al., 1991; Welsh et al., 2010). 
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Like other cells, SCN neurons can express self-sustained circadian rhythms (Welsh et al., 1995) 
but, unlike them, they are special in several important aspects. First, SCN neurons receive direct 
inputs from the environment, which allow them to synchronize to the day/night cycle. Light is 
the principal stimulus for external synchronization of circadian clocks, and in the context of 
mammals this is mediated via the direct retinal innervation of the SCN derived from the 
retinohypothalamic tract (RHT) (Abrahamson and Moore, 2001). Second, they have distinct, 
topographically organized coupling mechanisms which allow them to remain synchronized to 
one another even in constant darkness (Aton and Herzog, 2005). Third, through output 
pathways, they are able to synchronize other clocks in the central nervous system and periphery, 
orchestrating rhythms throughout the body (Gachon et al., 2004). Interestingly, these extra-
SCN regions are characterized by a variation in phase and amplitude of rhythmic clock gene 
expression (Kalsbeek et al., 2006; Harbour et al., 2014; Chun et al., 2015). 
Thus, the SCN master pacemaker synchronizes (“entrains”) to the light/dark cycle, and in turn 
synchronizes other oscillators throughout the brain and peripheral tissues (Figure 3). However, 
to date, the process (or processes) by which the SCN synchronizes all the others clocks, as well 
as a neuronal population synchronizes another neuronal population, is poorly understood. 
                   
Figure 3: Schematic representation of clocks distributed throughout the brain.  The SCN receives 
light input from the eyes through the retinohypothalamic tract and then it synchronizes other clocks in 
the CNS and periphery, thus orchestrating rhythms throughout the body. This image was adapted from 
Kyriacou and Hastings, 2010.  
The discovery of the SCN as the master circadian pacemaker dates back to the 70s. Although 
ablation studies had indicated a hypothalamic site for the circadian clock, the SCN only came 
to attention once autoradiographic tracing methods revealed it as the principal termination site 
of the retinohypothalamic tract. Subsequent studies showed that behavioral, endocrine and 
seasonal rhythms were compromised in damaged SCN. In addition, electrophysiological studies 
showed that activity in the SCN was rhythmic in vivo and that, using slices, the electrical 
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circadian rhythms were sustained in vitro, even when disconnected from the rest of the brain. 
The potency of this clock function was shown by intracerebral grafting, in vivo, of fetal SCN 
into the brain of mutant animals with abnormally short or long circadian periods. These grafts 
restored circadian patterning to the arrhythmic activity/rest behaviors, with a period determined 
by the genotype of the grafted tissue. This showed, definitively, that the SCN was necessary 
and sufficient to sustain circadian behaviors (Weaver, 1998; Herzog et al., 2017). 
2.2.2.1 Cellular organization of the SCN 
The SCN is a paired neuronal structure located in the anteroventral hypothalamus, on either 
side of the third ventricle, just above the optic chiasm (Klein et al., 1991). Each unilateral SCN 
contains ~10,000 neurons as well as a large number of neuroglia. Axons of SCN neurons 
terminate mainly within the nucleus itself, thus forming local circuit connections. A small 
amount of neurons send out projections from the SCN to distal targets, which are predominantly 
in the hypothalamus, midline thalamus and brain stem (Hastings et al., 2018). Nearly all SCN 
neurons produce γ-aminobutyric acid (GABA), although there are evidences that a 
subpopulation is glutamatergic (Csáki et al., 2000). 
Conventionally, the SCN is divided in two anatomic sub-divisions: a ventral “core” region 
which abuts the optic chiasm and receives direct input from the retina, and a dorsal “shell” 
region which partially envelops and receives input from the core. The core projects densely to 
the shell, which projects only sparsely back to the core (Welsh et al., 2010). Neurons in core 
and shell sub-regions are distinguished by neurochemical content. The core contains cells that 
express vasoactive intestinal peptide (VIP) or gastrin-releasing peptide (GRP), whereas the 
shell contains a dense population of neurons that express arginine vasopressin (AVP). A number 
of other neuropeptides, such as neurotensin, somatostatin and prokineticin2 (Prok2), are 
expressed in cells across the SCN, respecting or straddling these sub-divisions (Hastings et al., 
2019). 
To date, however, little is known about the mechanisms that mediate the entrainment of cells 
within the SCN. The major hypotheses in the field are two:  
ì) there are “non-rhythmic” SCN cells in the ventral core that respond directly to light inputs, 
as well as intrinsically “rhythmic” SCN clock cells in the dorsal shell that do not. 
Consequently, this hypothesis suggests that a light-induced phase shift occurs when non-
rhythmic cells in the ventral core communicate the lighting signal to the oscillator in the 
dorsal shell.  
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ìì) there are rhythmic neurons in the ventral core that directly or indirectly respond to light. 
Interactions between the oscillators in the ventral core and dorsal shell are responsible for 
light-induced phase shifts (Albers et al., 2017). 
2.2.2.2 SCN coupling mechanisms 
The most prominent network property of the SCN is the remarkable coupling of its constituent 
cellular oscillators to produce a coherent circadian oscillation at the tissue level. In striking 
contrast to the independent oscillations of dissociated cells, neurons within SCN tissue adopt 
identical circadian periods and similar phases, thus indicating a strong communication among 
these cells. How neurons communicate within the SCN, however, is not completely understood 
and much remains to be learned. There are a number of different types of signaling processes 
that may be responsible for communication among SCN cells.  
First of all, synaptic activity is an important form of communication among SCN neurons. 
Synaptic activity is essential for the expression of overt circadian rhythmicity and for the 
entrainment of the pacemaker with the Light-Dark (LD) cycle (Albers et al., 2017). An 
important role of synaptic signaling is based on observations that SCN neurons desynchronize 
when cultured with tetrodotoxin (TTX) to block Na+-dependent action potentials (Yamaguchi 
et al., 2003). However, there is also evidence that the SCN network can use other forms of 
coupling that do not depend on synaptic communication. In a study of 2011, Maywood and 
colleagues showed that co-cultured SCN slices are able to influence the rhythmic properties of 
one another even though they are unable to establish cross-slice synaptic connections, thus 
suggesting the presence of a paracrine signaling (Maywood et al., 2011). Consequently, the 
study of neurochemical signaling outside of classical synapses has become increasingly 
recognized as a significant form of inter-neuronal communication in the SCN. Inter-dendritic 
and inter-somatic appositions within the SCN have the potential to mediate non-synaptic 
interactions, and neurochemical signals can be released in non-synaptic regions of SCN 
neurons.  
Although it remains a challenge to fully map the neurochemical, temporal, and spatial 
properties of SCN circuits, different studies were performed to investigate the nature of the 
neurochemical signaling among SCN neurons.  
Within the core, VIP is the most prevalent neuropeptide transmitter, and recent studies have 
identified VIP in SCN coupling. VIP is released rhythmically from the core and acts through 
VPAC2 receptors in both core and shell. In mice lacking VIP, or its receptor, SCN cells are 
hyperpolarized and have low levels of Per1 and Per2 expression. These mice also have weak 
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behavioral rhythms. Daily application of a VIP agonist to mutant SCN cultures restores 
synchrony. Finally, VIP application to synchronized wild type SCN in vivo or in vitro produces 
phase-specific phase shifts similar to those of light. Thus, the synchronizing function of the 
SCN core requires VIP release from synaptic terminals at target neurons throughout the SCN 
(Nielsen et al., 2002; Harmar et al., 2002; Colwell et al., 2003; Welsh et al., 2010). 
Since it was reported that nearly all SCN neurons express GABA, this neurotransmitter was 
indicated as a potential regulator of SCN communication. In 2000, Liu and Reppert showed 
that GABA, acting through A-type receptors, can induce phase shifts in single clock cells in 
culture, and the amplitude and direction of the phase shifts is determined by the phase of clock 
cells at the time of the treatment. Furthermore, daily treatments with GABA can synchronize 
cultured clock cells (Liu and Reppert, 2000). On the other hand, neurons in SCN slices remain 
synchronized in the presence of GABAA and GABAB antagonists (Aton et al., 2006), thus 
indicating that GABA is sufficient but not necessary for the SCN coupling. In summary, VIP 
is necessary for SCN coupling, but other neurotransmitters, including GABA, can also 
contribute or play a modulatory role. 
It is also important to highlight that coupling mechanisms do not involve only neurons within 
SCN. It is demonstrated that various brain regions, including the prefrontal cortex, 
hippocampus, amygdala and dentate gyrus, exhibit circadian modulations in molecular 
expressions. When isolated from the SCN in vivo, either by ablating the SCN or by encircling 
it with a knife cut, the periodicity in extra-SCN regions is abolished, thus suggesting that the 
central pacemaker within the SCN is responsible for driving near 24h rhythmicity in other 
regions of the brain (Abe et al., 2002). Interestingly, the phase and amplitude of the rhythms of 
clock genes vary across regions (Harbour et al., 2014; Chun et al., 2015). This reveals the 
presence of important regional differences in the temporal dynamics underlying local daily 
rhythm generation in the mammalian forebrain. This observation also underscores the complex 
temporal organization of subordinate circadian oscillators in the forebrain and raises interesting 
questions about the connection of these oscillators with the master SCN clock. To date, in fact, 
it remains unknown how specific circadian cues are conveyed from the SCN to most 
downstream targets to control physiology and behavior.  
2.2.3 The role of astrocytes 
The central and peripheral nervous system is characterize by the presence of non-neuronal cells, 
known as glia. Astrocytes, also known collectively as astroglia, are characteristic star-shaped 
glial cells and represent the largest population of the glial subtype in the brain. Thanks to its 
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shape, in humans a single astrocyte cell can interact with up to 2 million neurons at a time 
(Fields et al., 2014).  
Astrocytes perform many functions in the brain, including biochemical support of endothelial 
cells that form the blood–brain barrier, provision of nutrients to the nervous tissue, and a role 
in the repair and scarring process of the brain following traumatic injuries. Furthermore, they 
exert essential functions in maintaining the fluid, ion, pH, and transmitter homeostasis of the 
synaptic interstitial fluid in a manner that is critical for healthy synaptic transmission. Astrocyte 
processes at synapses also play essential roles in transmitter homeostasis by expressing high 
levels of transporters for neurotransmitters such as glutamate, GABA, and glycine that serve to 
clear the neurotransmitters from the synaptic space. After uptake into astrocytes, the 
transmitters are converted by enzymes such as glutamine synthetase into precursors such as 
glutamine and recycled back to synapses for reconversion into active transmitters (Sofroniew 
and Vinters, 2010). There is now steadily accumulating evidence that astrocytes play direct 
roles in synaptic transmission through the regulated release of synaptically active molecules 
including glutamate, purines (ATP and adenosine), GABA, and D-serine. Such evidence has 
given rise to the ‘tripartite synapse’ hypothesis, which posits that astrocytes play direct and 
interactive roles with neurons during synaptic activity in a manner that is essential for 
information processing by neural circuits (Halassa et al., 2007; Perea et al., 2009). 
Unlike neurons, astrocytes do not ‘fire’ or propagate action potentials along their processes. 
However, this does not mean that they are physiologically ‘silent’. Astrocytes, in fact, express 
potassium and sodium channels and can exhibit evoked inward currents. Moreover, they exhibit 
regulated increases in intracellular calcium concentration [Ca2+]i that are of functional 
significance in astrocyte–astrocyte as well as in astrocyte–neuron intercellular communication. 
Astrocyte [Ca2+]i elevations can (1) occur as intrinsic oscillations resulting from Ca
2+ released 
from intracellular stores, (2) be triggered by transmitters (including glutamate and purines) 
released during neuronal activity, (3) elicit the release from astrocytes of transmitters such as 
glutamate into the extracellular space and thereby trigger receptor mediated currents in neurons, 
and (4) be propagated to neighboring astrocytes (Sofroniew and Vinters, 2010). It is also 
noteworthy that astrocytes can couple to neighboring astrocytes through gap junctions formed 
by connexins and creating the so called “syncytium”. An increase in intracellular calcium 
concentration can propagate outwards through this functional syncytium, generating calcium 
waves propagating through the network of astrocytes. Mechanisms of calcium wave 
propagation include diffusion of calcium ions and IP3 through gap junctions and extracellular 
ATP signaling (Newman, 2001). Calcium elevations are the primary known axis of activation 
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in astrocytes, and are necessary and sufficient for some types of astrocytic glutamate release 
(Parpura and Haydon, 2000). Importantly, because of this ability of astrocytes to communicate 
with their neighbors, changes in the activity of one astrocyte can have repercussions on the 
activity of others cells that are quite distant from the source astrocyte. 
2.2.3.1 Astrocytes as clock cells 
In 2005 Prolo and colleagues, using rat and mouse astroglia obtained from transgenic animals 
expressing a per-luciferase (per-luc) reporter, demonstrated for the first time that astrocytes 
fulfill the criteria of circadian oscillators: they have intrinsic circadian clocks with a genetically 
defined, temperature-compensated period that can be entrained to daily environmental cycles 
(Prolo et al., 2005). It was shown that astrocytes exhibit circadian rhythms of clock gene 
expression, with the consequence of a remarkable circadian variation in morphology. 
Astrocytes, in fact, express high levels of glial fibrillary acidic protein (GFAP), which exhibits 
24 h oscillations in its distribution, both in light-dark conditions and in constant darkness 
(Lavialle and Servie` re, 1993; Santos et al., 2005). Furthermore, astrocytes exhibit a strong 
circadian cycle of intracellular calcium ([Ca2+]i): they are circadian cells just as neurons are, 
but the peak of the [Ca2+]i rhythm in astrocytes is much broader than the sharp peak of neurons. 
More importantly, it phases to circadian night (at about CT18), indicating that the activity cycle 
of astrocytes in the SCN runs in anti-phase to that of SCN neurons (Brancaccio et al., 2017). 
This differential phasing between neurons and astrocytes was demonstrated also at the TTFL 
level, with Cry1-luciferase in astrocytes peaking in circadian night. Surprisingly, therefore, the 
SCN circadian network incorporates two functionally distinct cellular populations: day-active 
neurons and night-active astrocytes harnessing a differentially phased TTFL (Brancaccio et al., 
2019). 
Unlike the sustained oscillations observed in neurons (Welsh et al., 1995), rhythms in cortical 
glia damps after several cycles in vitro. Damping may reflect a gradual desynchronization 
among a population of sustained oscillators or a loss of rhythmicity in individual cells, 
suggesting an essential difference in molecular rhythm generation between neurons and cortical 
glia. Importantly, circadian rhythms in astrocytes can be phase shifted and entrained to a 
physiologically relevant cycle, suggesting that, in vivo, glia continue to oscillate as a result of 
periodic signaling. In cell cultures, rhythms can be reinitiated by culture medium replacement 
or treatments with the calcium ionophore Calcimycin or the adenylate cyclase agonist 
Forskolin. It was suggested that all these stimuli may be acting on the molecular clock through 
a common mechanism, such as the elevation of intracellular Ca2+ levels (Jackson, 2011). 
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2.2.3.2 Astrocytes control molecular and behavioral rhythms: the astrocyte- 
neuron communication 
Astrocytes are not passive clock cells. Pharmacological inhibitors of glial activity affect the 
rhythms of SCN neuronal firing and diurnal behavioral rhythms, thereby suggesting that glial 
cells could play a role as synchronizers of circadian networks within the SCN (Prosser et al., 
1994). In support of this notion, a series of recent studies have demonstrated that astrocytes 
play an important role in circadian timekeeping and behavior as any neuronal cell. Tso et al. 
have shown that loss of rhythms in SCN astrocytes through Bmal1 deletion leads to a 
lengthened circadian period of rest-activity rhythms (Tso et al., 2017). By an alternative 
astrocyte-targeting strategy, in our laboratory and in collaboration with Davide De Pietri 
Tonelli, Barca-Mayo et al. have shown that Bmal1 deletion dysregulates PER2 and VIP 
expression in the SCN and alters daily locomotor activity and cognitive functions (Barca-Mayo 
et al., 2017). Successively, Brancaccio et al. have shown that SCN astrocyte-specific deletion 
of the mutant version of the clock kinase Csnk1eTau lengthened the period of behavioral rhythms 
from 20 to 24h (Brancaccio et al., 2017). These phenotypes strengthen the importance of 
astrocytes as potent regulators of molecular and behavioral rhythms. All together, these results 
revealed that astrocytes are not only embedded in the clock circuit, but they also are major 
determinants of its period length. In addition, a recent study reveals the crucial contribution of 
astrocytic clock in the circadian regulation of metabolism and lifespan (Barca-Mayo et al., 
2020). The results highlighted by these studies imply the importance of reciprocal interactions 
between astrocytes and neurons in the context of circadian circuitry. 
There are different signaling pathways involved in the astrocytic control of SCN function. As 
a GABAergic circuit, the SCN is sensitive to extracellular GABA concentrations, which are in 
part controlled by GABA transporters that are expressed on SCN astrocytes. Blockade of these 
transporters in astrocytes not only affects tonic and synaptic GABAA receptor currents in SCN 
neurons but also shortens the period of the TTFL (Moldavan et al., 2017). Moreover, in vitro 
co-culture experiments showed that synchronous astrocytes are able to entrain rhythmicity in 
neurons with a mechanism that is mediated by GABA and GABAA receptor signaling (Barca-
Mayo et al., 2017). 
In addition, astrocytes can also exert more direct effects on neurons via the release of 
gliotransmitters. In the specific context of the SCN, astrocytes have been implicated in 
modulating the response of the neuronal clock to pro-inflammatory cytokines, and several 
candidate gliotransmitters, including extracellular ATP, are regulated in a circadian manner in 
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cultured astrocytes and cultures of the SCN2.2 cell line (derived by adenoviral immortalization 
of rat SCN cells) (Hastings et al., 2018). In addition, glutamate, a major gliotransmitter in the 
SCN, also shows daily oscillations. When detected with fluorescence live imaging, its 
extracellular concentration was shown to be directly in phase with astrocytic [Ca2+]i and to 
share a similar waveform. This suggests that glutamate contributes to astrocytic circadian 
signaling. Furthermore, as shown by two independent pharmacological approaches, i.e. 
interference with glutamate release by astrocytes (via Cx43 inhibition) and with neuronal 
glutamate sensing (via NMDAR2C antagonism), glutamate is a necessary mediator of 
astrocytic control of circadian function in the SCN (Brancaccio et al., 2017; Brancaccio et al., 
2019). 
Although the role of GABA and glutamate in the circadian field is still not completely clear and 
rather controversial, these two transmitters may act together as powerful circadian 
synchronizers to combine the effects of their activities in both the astrocytic and neuronal 
compartments of the SCN circuit. 
2.2.4 Microfluidics for cell-cell communication studies 
The study of cell-cell communication, or cell-cell signaling, is important in many biological 
fields, including neuroscience, genetics, cancer, immunology, and more. How two or more cells 
talk and interact has drastic effects on proliferation, differentiation, migration, and stimulation, 
while defects in cellular communication can lead to diseases. Some examples of cellular 
communication include immune-tumor cell interactions, both at the immunological synapses 
and through secretion of cytokines and growth factors, communication within neural networks, 
neural and optical synapse formation, and signal propagation. Therefore, the study of cell-cell 
communication is necessary for both understanding diseases and for creating novel biomedical 
technologies.  
The best method for studying intercellular communication is by using in vitro tools that 
facilitate isolation and control of the microenvironment (Vu et al., 2017). Although there is a 
clear need to advance in understanding cell-cell communication, these studies remain 
challenging and prevent scientists’ ability to conduct these studies. One of these challenges is 
the involvement of different mechanisms in cell-cell communications and, consequently, the 
need of different and specific techniques to specifically study the multiple types of 
communication pathways, including gap junction signaling, paracrine signaling, endocrine 
signaling and synaptic/direct signaling (Nahavandi et al., 2014). To date there exists no general 
platform that can lever all these requirements for studying every pathway in cell-cell 
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communication. To better study all of these individual phenomena for a variety of scenarios, 
specific tools designed for each application need to be available to researchers.  
The most common tools and techniques that have been used to study cell-cell communication 
are transwell systems and co-culture systems (Goers et al., 2014). Transwell inserts are one of 
the oldest technology for co-culture and consist in two separate compartments with multiple 
surfaces to culture. They are used for communication studies like secretion, differentiation, and 
migration. However, there are some limits in using the transwell system, such as the lack of 
physiological relevance, flow, difficulty for imaging, and limited spatial control. Co-culture 
systems can include heterogeneous cell cultures on Petri dishes, co-culture in gels, or 
bioreactors. These methods, however, lack of the ability to be easily customized and versatile 
for many different scenarios, such as gradient culture, different cell sizes, spatial control, and 
more. To overcome these issues and enhance biological studies, microfluidic technology and 
the development of microfluidic cell culture devices was proposed and increasingly used in the 
past two decades.  
Microfluidics allows to realize devices known as micro total analysis systems (μTAS), or lab-
on-a-chip systems. It converges the science and technology of systems that process or 
manipulate small amounts of fluids, using channels with dimensions of tens to hundreds of 
micrometers. It originated from the miniaturization of analytical chemistry and biomedical 
applications on a chip in the early 1990s and, since then, research on microfluidics has grown 
to a large community and let to different applications (Zhong et al., 2019), including 
commercially available products.  
According to the different experimental needs, cell culture conditions are usually divided into 
two major classes that can be distinguished as in a “static state” or a “dynamic state”. The “static 
state” is characterized by a sufficient medium supply for the maintenance of on-chip cells 
without the use of any perfusion system. The chip is always placed into an incubator and the 
cell culture medium is typically exchanged daily or even after longer time, a condition that may 
help to observe the natural performance of cells. The “dynamic state” usually includes the use 
of some extra auxiliary equipment, such as a micropump, to change medium or even separate 
cells. This approach provides opportunities for cell manipulation and to precisely control the 
delivery of pharmacological stimuli (Li et al., 2016). Both static or dynamic cell culture 
conditions can be realized with microfluidic devices.  
The most common material for realizing cell culture microfluidic devices is 
polydimethylsiloxane (PDMS), an elastomeric material which is featured by air permeability, 
flexibility and biocompatibility. Microfluidic systems based on PDMS can be realized via 
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photolithography, as proposed in 1998. Photolithography offers procedures for fabricating 
networks of channels (typically >20 μm width) rapidly and at low cost. To do so, PDMS 
microfluidic devices are replicated from photolithographically fabricated masters (such as 
silicon microstructured wafers). These devices support a wide variety of applications because 
of their good biocompatibility, optical transparency, and flexibility (Zhong et al., 2019). 
Various types of cells, like adherent and non-adherent cells, have been cultured in microfluidic 
platforms (Yamazoe et al., 2016) that met the strict requirement of defining stable cellular 
microenvironments. Several novel discoveries on cell structures, characteristics and behaviors, 
obtained with the support of microfluidic platforms are reported in the literature (Kim et al., 
2008; Tazawa et al., 2015). Hence, microfluidic systems are increasingly used in biology and 
pahramcology as versatile tools and viable alternatives to traditional approaches for several 
specific applications, such as: single-cell studies, cell trapping, filtration, cell rolling and 
investigations, detection of biomarkers, drug screening and discovery, cryopreservation of cells 
(Coluccio et al., 2019). 
Recently, microfluidic devices have been coupled with microsystems engineering, tissue 
engineering, biomimetic principles and cell biology to develop organ-on-a-chip systems. Such 
organ-on-a-chip usually involve a scaffold, suitable cellular microenvironments, and artificial 
organ-level stimuli for the formation of viable tissues and organ models. Microfluidics is 
capable of the precise control of dynamic fluids and pressures at a micrometer scale. Therefore, 
in combination with microfabrication technologies, it can provide 3D scaffolds and precisely 
controlled microenvironments with suitable biochemical and physicochemical stimuli. These 
novel systems are now being utilized to establish physiologically relevant, functional, single- 
or multi-organ models on a single chip, and are becoming increasingly used tools for 
physiological and pathological studies, and pharmaceutical applications (Zhong et al., 2019; 
Park et al., 2019). Even cell-cell communication studies can be greatly enhanced by 
microfluidic technology. One of the advantages of microfluidics is the ability to spatially 
manipulate cells with a precision unmet by traditional cell culture technologies. For instance, 
this allows to spatially control cells individually or collectively. Another advantage is the ease 
of introducing flow and gradient control capabilities. All these features can be combined with 
the uniqueness of microfluidics to implement devices for both population-based and single cell 
studies (Mao et al., 2013; Vu et al., 2017). 
Unsurprisingly, a wide range of microfluidic devices were developed for studying interactions 
between cells in the central nervous system (Rothbauer et al., 2018) (Figure 4). Notably, Taylor 
et al. studied the effect of chemical injuries between two spatially resolved neural cell culture 
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compartments (Taylor et al., 2010). Higashimori et al. combined a microfluidic co-culture 
system with imaging instrumentation to examine cell-to-cell interactions between 
axonal/dendritic and glial cells (Higashimori and Yang, 2012).  For the precise control over 
CNS injuries and lesions, Kim et al. introduced a microfluidic platform that was capable of 
controlling axonal growth by surface modification, as well as controlling soluble factors (Park 
et al., 2006; Kim et al., 2012), and Park et al. established a complex microfluidic 3D platform 
for studying axon-glia interactions during drug and biomolecule treatment on multiple co-
cultures (Park et al., 2012). Another technological advance in chip-based neurobiology includes 
the possibility of exploiting the integration of microvalves for opening and closing connecting 
conduits between neighboring cell culture compartments. This allows, for instance, to study 
interactions between spatially resolved neurons and glial cells (Gao et al., 2011; Majumdar et 
al., 2011). 
Overall, although microfluidic devices emerged a century ago but their development and 
application did not reached a saturation yet. This field is regularly progressing by targeting 




Figure 4: Examples of microfluidic devices for cell-to-cell communication studies. A) Co-culture of 
neurons and glia in the microfluidic platform (Majumdar et al., 2011). B) Schematic representation of a 
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microfluidic device (left) and phase-contrast micrographs of axons (right) for investigating injury and 
regeneration of CNS axons (Park et al., 2006; Kim et al., 2012). C) Microfluidic device for cell-to-cell 
communication study (Mao et al., 2012). D) 3D illustration of the multi-compartment neuron-glia co-





































Since the circadian clock plays a fundamental role in the maintenance of circadian-dependent 
processes, understanding its regulatory mechanism among neuronal populations is vitally 
important. In mammals, the suprachiasmatic nucleus (SCN) of the hypothalamus is the master 
circadian pacemaker which coordinates circadian rhythms in the central nervous system (CNS) 
and across the entire body. Interestingly, the phase and amplitude of the rhythms of clock genes 
vary across brain regions (Harbour et al., 2014; Chun et al., 2015). This underscores the 
complex temporal organization of subordinate circadian oscillators in the forebrain and raises 
interesting questions about the connection of these oscillators. In particular, an important aspect 
that remains unclear is how so many and distant neural clocks in the nervous system can be 
effectively synchronized. About this, it is important to remember that SCN neurons do not 
project to long distances in the brain (Watts et al., 1987). Therefore, distant cells need other 
channels of communication in order to be able to synchronize distant clocks.  
An unspoken tenet in the circadian field is that neurons, and in particular SCN neurons, do the 
lion’s share of this work. A series of recent studies, however, challenged this view by 
demonstrating important roles for astrocytes in entraining rhythmicity in neurons (Tso et al., 
2017; Barca-Mayo et al., 2017; Brancaccio et al., 2017; Brancaccio et al., 2019). 
In light of these recent findings, the working hypothesis that I investigated in this work is 
whether astrocytes and/or paracrine factors released by neurons may define long-range 
communication channels to synchronize molecular clocks among distant and segregated 
neuronal populations. Consequently, by exploiting a microfluidic platform specifically 
developed for this study, the specific aims of my PhD were to study in an in vitro model:  
i) whether paracrine factors, released by a synchronous neuronal population, or astrocyte 
networks can transfer neural circadian information among distant neuronal populations,  
ii) how this signaling might occur and, ultimately,  
iii) whether these two pathways occur regardless of the distance between the two neuronal 
populations. 
Knowing that an alteration in the astrocyte intercellular communication or of astrocytic clock 
genes might contribute to the impairment of the neurobehavioral outputs or to disorders 
associated with the timekeeping system (McKee et al., 2020), in the last period of my PhD I 
also started to investigate effects related to reactive astrocytes and their implications to 




2.4 Materials and methods 
2.4.1 Microfluidic device design and fabrication 
In this part of my work I contributed to the development of a two-compartment microfluidic 
device that was realized to experimentally investigate our hypothesis and, specifically, the 
involvement of astrocytes and/or paracrine factors to synchronize molecular clocks among 
distant and segregated neuronal populations. 
The realization of the microfluidic device consists in mounting on a 4’’ glass wafer a micro-
structured polydimethylsiloxane (PDMS) (Sylgard 184, Sigma-Aldrich) layer. This layer 
defines the microfluidic circuitry and it was obtained as replicas from a Si master by using the 
so-called micromolding technique (Figure 5). Positive structures on the Si master were obtained 
by patterning a Cr layer with optical lithography and dry etching the Si substrate using DRIE 
(Deep Reactive Ion Etching). To do so, 4” p-type Si wafers were first cleaned by subsequent 
acetone, isopropyl-alcohol and deionized water (DI) washing. Next, positive tone photoresist 
(MEGAPOSIT SPR 200, MicroChem) was deposited by spin coating (4000 rpm) onto the Si 
wafer and baked at 115 °C for 2 min. The microfluidic circuitry was patterned by exposing the 
photoresist to UV light (MA-6, SUSS MicroTec mask align) through a laser written lithography 
mask and developed for 1 min in Microposit MF-319 developer. Successively, a 200 nm thick 
Cr layer was deposited by DC sputtering (Kenosistec KS500 Confocal) at 1 Å/s deposition rate 
and unwanted Cr remaining on the photoresist was lifted-off in acetone (overnight). The Cr 
patterned layer was then used as mask for dry-etching process. A DRIE Bosh process 
(SENTECH SI500, ICP-RIE) was employed to etch the Si for 80 μm and the depth measured 
by mechanical profilometer (Dektak 150). This thickness defines the final depth of the 
microfluidic channel between the two wells in the PDMS replicas. 
The processed Si wafer was then cleaned by O2 plasma (100 W, 300 s) and the Cr layer removed 
in a Cr etchant solution. Finally, a fluorosilane anti-sticking layer was deposited onto the Si 
wafer to facilitate PDMS removal in the molding process. To do so, a 250 μl of 
Perfluorooctyltriethoxysilane (POTS, Alfa Aesar L16606) were dispensed onto a glass slide 
and placed under vacuum with the Si wafer for 1 hour. The wafer was then baked on a hot plate 
at 80°C for 5 min. 
PDMS was prepared by mixing the curing agent and PDMS monomers in a ratio 1:10. After 
degassing under vacuum, it was deposited onto the structured Si mold (approximately 4 mm in 
height) and cured at 65 °C in oven for 2 hours. Then, the cured PDMS was peeled-off from the 
Si mold, thus obtaining negative microfluidic structures, i.e. replica of the positive structures 
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defined onto the Si wafer. A hole punch of 8 mm in diameter was used to realize the two wells 
through the PDMS layer, while a 1 mm in diameter hole punch was used to make the holes for 
the input microfluidics used to compartmentalize the cultures. Next, this PDMS structured layer 
was mounted on a glass wafer, previously cleaned by subsequent acetone, isopropyl-alcohol 
and DI water washing. To allow the fixing of the PDMS on the glass wafer, the surfaces of both 
the substrate and the PDMS were treated in O2 plasma (20 W, 30 s). Finally, glass cylinders (15 
mm in diameter, 10 mm in height) were fixed on the PDMS device to create the cell culture 
wells. As PDMS is hydrophobic, it is necessary to make it hydrophilic to allow cell growth. To 
do so, the device was treated in O2 plasma (100 W, 120 s). 
The realized PDMS microfluidic devices consist of two chambers communicating through a 3, 
10 or 17 mm long microfluidic channel (80 μm in height, 300 μm in width). Additional 
microfluidic channels, perpendicular to the interconnecting one, are used to continuously 
perfuse media in order to compartmentalize in a fluidic manner the two cell culture wells. 
 
Figure 5: Microfluidic device fabrication. A) Schematic illustration of the fabrication process of the 
PDMS microfluidic device. B) Illustration of the microfluidic circuitry. 
2.4.2 Microfluidic device validation 
Microfluidic testing of the functionality of the vertical fluidics developed to compartmentalize 
the two cell culture wells was performed by applying a Coomassie Brilliant Blue dye (Sigma 
27815) in one of the wells, both with/without vertical perfusion. Such perfusion was performed 




2.4.3 Primary astrocyte culture 
All animal procedures carried out in this work were approved by the institutional IIT Ethics 
Committee and by the Italian Ministry of Health and Animal Care (Authorization No. 
110/2014-PR of the 19th of December 2014). 
Primary monolayer cultures of astrocytes were established from cerebral cortices of neonatal 
(P1–P3) Sprague–Dawley rats and maintained at 37°C in a humidified atmosphere of 5% CO2. 
The following solutions and media were used: Hanks Balanced Salt Solution (HBSS) (Sigma 
H6648); digestion solution  ̶  Dispase II 2mg/ml (Roche 04942078001) in Phosphate-Buffered 
Saline (PBS) (Thermo Fisher Scientific 10010056) + DNAse I 25µg/ml (Sigma D5025) in PBS; 
complete medium  ̶  DMEM/F-12 (Sigma D6421) supplemented with 1% Glutamax (Thermo 
Fisher Scientific  35050038), 1% Penicillin/Streptomycin (Sigma P4333) and 10% FBS (Sigma 
F7524). Briefly, pups were removed and decapitated, and the brains were extracted from the 
skulls and placed in cold HBSS. After dissection, cortices were disaggregated by pipetting, 
placed in the digestion solution and incubate in water bath at 37°C for 30 min. Cell solution 
was centrifuged at 900 rpm for 5 min, and the supernatant was removed. The cell pellet was 
resuspended in complete medium (considering 10ml per pup). The solution was filtered with a 
cell strainer (Biologix 15-1040, 40 µm pore size), and cells were plated in flasks (considering 
1 flask per pup). The day after plating, the medium was changed to remove dead cells. The 
cultures were maintained at 37°C in a humidified atmosphere of 5% CO2 for 1 week and 
thereafter cells were trypsinized and subcultured for the different experiments. 
2.4.4 Primary neuronal culture 
Primary neuronal cultures were established from cerebral cortices of embryonic day 18 (E18) 
Sprague–Dawley rats and maintained at 37°C in a humidified atmosphere of 5% CO2. The 
following solutions and media were used: Hanks Balanced Salt Solution (HBSS) (Sigma 
H6648); digestion solution  ̶  Trypsin 0,125% (Thermo Fisher Scientific 25050014) in HBSS + 
DNAse 0,25 mg/ml (Sigma D5025) in HBSS 5mM CaCl2; complete Neurobasal  ̶  Neurobasal 
medium (Thermo Fisher Scientific 21103049) supplemented with 2% B27 (Thermo Fisher 
Scientific 17504044), 1% Glutamax (Thermo Fisher Scientific 35050038) and 1% 
Penicillin/Streptomycin (Sigma P4333); FBS (Sigma F7524).  
Briefly, embryos were removed and decapitated, and the brains were extracted from the skulls 
and placed in cold HBSS. After dissection, cortices were placed in the digestion solution and 
incubate in water bath at 37°C for 30 min. Few ml of complete Neurobasal + 10% FBS were 
added to the cell solution. It was centrifuged at 1200 rpm for 5 min, and the supernatant was 
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removed. The cell pellet was resuspended in fresh complete Neurobasal + 10% FBS and gently 
pipetted for not more than 10 times with P1000 pipette. The solution was filtered with a cell 
strainer (Biologix 15-1040, 40µm pore size), centrifuged at 700 rpm for 7 min, and the 
supernatant was removed. The cell pellet was resuspended in complete Neurobasal. Cell 
viability at the time of isolation was determined by a Trypan Blue Exclusion Assay (Sigma 
T8154). Cells were plated at a density of 90,000 cells/well onto coverslips coated with poly-D-
lysine (PDL) 0.1 mg/ml (Sigma P6407) in 24-well dishes. Five days after plating, half of the 
medium was added, and subsequently every 4–5 days half of the medium was changed. 
Neuronal cultures were maintained for up to 3 weeks in vitro before being used for the different 
experiments. 
2.4.5 Microfluidic device experiments and treatments  
In experiments, the microfluidic device was used either with astrocytes interconnecting the two, 
wells in which neuronal populations are placed, or without astrocytes to study the effect of 
released paracrine factors.  
In the first experimental condition, cortical astrocytes were plated in the microchannel and in 
the two wells of the microfluidic device. Once confluent (3-4 DIVs) the medium in the device 
was replaced with 50% complete Neurobasal + 50% conditioned Neurobasal. The day after, the 
fluidic connectivity between the two chambers of the microfluidic device with cultured 
astrocytes was blocked by perfusing 50% complete Neurobasal + 50% conditioned Neurobasal. 
Then, neurons at 22-24 DIVs that were grown separately on coverslips, were synchronized with 
Dexamethasone 100nM (Sigma D4902) for 2h and successively placed upside-down in one 
well of the device (N1). An untreated asynchronous neuronal culture (N2) grown in the same 
conditions of N1 was placed in the other well of the device. In the second experimental 
condition, i.e. without astrocytes, experiments were performed by placing neuronal cultures 
grown on coverslips in the two wells. For experiments with pharmacological compounds such 
as inhibitors, compounds were added directly in the well, just before placing N2. 
All cellular populations in the two wells (i.e. N1, A1 and N2, A2) were harvested at different 
time points for subsequent qPCR analysis, and all experiments were performed in triplicate by 
exploiting the integration of multiple distinct microfluidic devices on the same PDMS layer. 
For the different experimental conditions detailed in the results section, the following 
compounds were used: DQP1105 50µM (Tocris Bioscience 380560-89-4), Bicuculline 30µM 
(Sigma B7561), Glutamate 400µM (Sigma 49449), GABA 100µM (Sigma A2129), CNQX 
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10µM (Tocris Bioscience 479347-85-8), Gap26 100µM (AnaSpec AS-62644), 2-APB 100µM 
(Tocris Bioscience 524-95-8), TNFα 200ng/ml (PeproTech 315-01A). 
2.4.6 Immunofluorescence imaging of astrocytes  
Cortical astrocytes were plated on coverslips coated with PDL 0.01 mg/ml in 24-well dishes. 
Once astrocytes were confluent, some of them were treated with TNFα 200ng/ml (2h). 24h after 
the treatment, treated astrocytes and control (not treated) astrocytes were washed with PBS and 
fixed with PFA 4% for 15 min. For the immunostaining, fixed astrocytes were treated with PBS 
+ Triton 0.1% (PBST) for 20 min at room temperature (RT), blocked with PBST + 10% normal 
goat serum (NGS) for 1h at RT, and subsequently incubated in primary antibodies (rabbit  anti-
cleaved caspase3, Cell signaling 9664, 1:400) diluted in PBST + 5% NGS overnight at 4°C. 
The day after, astrocytes underwent 3 washes with PBST and subsequently were incubated with 
secondary antibodies (Alexa488 goat anti-rabbit, Invitrogen A11034, 1:1000) diluted in PBST 
+ 5% NGS for 45 min at RT. Astrocytes underwent 3 washes in PBST, followed by 1 in PBS. 
Nuclei were counterstained with DAPI. All images were acquired with 40x objective lenses 
using a Leica SP5 inverted confocal microscope (Leica Microsystems). 
2.4.7 RNA isolation and quantitative real-time PCR (qPCR) 
Cells were harvested at the appropriate time points and at a time interval of 6 hours. Total RNA 
was extracted using TRIzol reagent (Invitrogen 15596018) following the manufacturer’s 
instructions. RNA was further cleaned using a DNase I Kit (Sigma AMPD1). Complementary 
DNA (cDNA) was obtained by reverse transcription of 300 ng of total mRNA using the M-
MuLV-RH First Strand cDNA Synthesis Kit (Experteam R01-500) following the 
manufacturer’s instructions. Real-time reverse transcriptase–PCR was done using the 7900HT 
Fast Real-Time PCR System (Applied Biosystems). For a 10 ml reaction, 9 ng of cDNA 
template was mixed with the primers (final concentration: 400nM each primer) and with 5 µl 
of 2x iTaq Universal SYBR Green Supermix (Biorad 172-5124). The reactions were done in 
duplicates using the following conditions: 30 s at 95°C followed by 40 cycles of 15 s at 95°C 
and 60 s at 60°C. The primers used are listed in Table 1. Relative quantification was used to 
detect changes in the expression of the genes of interest relative to a reference gene (Gapdh). 




GENE SEQUENCE 5’-3’ 
Gapdh - Forward TGTGTCCGTCGTGGATCTGA 
Gapdh - Reverse CCTGCTTCACCACCTTCTTGA 
Bmal1 - Forward CCGATGACGAACTGAAACACCT 
Bmal1 - Reverse TGCAGTGTCCGAGGAAGATAGC 
Per2 - Forward CACCCTGAAAAGAAAGTGCGA 
Per2 - Reverse CAACGCCAAGGAGCTCAAGT 
Dbp - Forward CCTTTGAACCTGATCCGGCT 
Dbp - Reverse TGCCTTCATGATTGGCTG 
Clock - Forward TCTCTTCCAAACCAGACGCC 
Clock - Reverse TGCGGCATACTGGATGGAAT 
Cx43 - Forward ACAGCTGTTGAGTCAGCTTG 
Cx43 - Reverse GAGAGATGGGGAAGGACTTGT 
GFAP - Forward ACCAGCTTACTACCAACAG 
GFAP- Reverse CCAGCGACTCAACCTTCCTCT 
Serpina3n - Forward CCTGGAGGACGTCCTTCCA 
Serpina3n - Reverse TCATCAGGAAAGGCCGGTCG 
Lcn2 - Forward CTGGCAGCGAATGCGGTCCA 
Lcn2 - Reverse TGTTCTGATCCAGTAGCGAC 
 
Table 1: Primers used in this work for qPCR (Gapdh transcript as control). 
2.4.8 Statistical analysis 
Data are presented as mean±s.e.m. and were analyzed and graphed using Prism 5 (GraphPad, 
San Jose, CA, USA). Statistical significance of the rhythmic expression was determined by 
Cosinor analysis (expression data was fit by a nonlinear least-squares regression with the 
following equation: y = a + b × cos [2π (t  ̶  c)], where a is the rhythm-adjusted mean, b is the 
amplitude of the rhythm, c is the phase given in circadian time representing the time of peak 
expression and t is the circadian time). P<0.05 was considered as statistically significant and 





2.5 Results and discussion  
In order to study the synergic regulation of clock genes among neurons and astrocytes, and to 
evaluate the possible pathways involved in the transmission of circadian information among 
distant neural populations, this work was developed using an in vitro model based on a lab-on-
a-chip microfluidic device developed in our laboratory. This device allows growing and 
compartmentalizing distinct neural populations, connected (or not) through a network of 
astrocytes, to manipulate their clocks and to use real-time quantitative polymerase chain 
reaction (qPCR) to profile clock genes expression over time. 
2.5.1 Specifications and performance of the realized microfluidic device 
The lab-on-a-chip device was designed with two distant wells interconnected by a long 
microfluidic channel (80 μm in height, 300 μm in width and, if not specified differently, 3 mm 
in length). Six additional microfluidic channels, perpendicular to the interconnecting one, are 
used to continuously perfuse media in order to compartmentalize in a fluidic manner the two 
cell culture wells. This was developed by considering enabling to i) seed and grow a network 
of astrocytes covering both wells as well as the interconnecting channel when investigating the 
astrocytes-mediated neuronal synchronization; ii) place neural cultures grown on glass cover-
slips in each well, leaving the channel without cells (i.e. “empty” and with only cell culture 
medium) when investigating paracrine factors-mediated neuronal synchronization and iii) use 
microfluidics to segregate each well, thus avoiding extracellular signaling between the 
populations in the two wells and leaving only the astrocyte network interconnecting through 
cell-to-cell interactions the two neural populations.  
The fabrication process of these microfluidic devices is depicted in Figure 5A and detailed in 
the “Materials and Methods” section. It consists in mounting on a 4’’ glass wafer a micro-
structured Polydimethylsiloxane (PDMS) layer. This layer defines the microfluidic circuitry 
and it was obtained as replicas from a Si-master by using the so-called “micromolding 
technique” (Figure 6A). Each device provides 4 pairs of interconnected wells (Figure 6B). 
Microfluidic testing of the functionality of the vertical fluidics developed to compartmentalize 
the two cell culture wells was performed by applying a Coomassie Brilliant Blue dye in one of 
the wells, both with/without vertical perfusion (Figure 6C). As shown, without the vertical 
perfusion the dye can flow from one well to the other one. Only when applying the vertical 
perfusion, the dye remains confined in the first well, resulting in a complete separation of the 
two chambers. Therefore, these results show that this device can be used: i) without vertical 
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perfusion, to investigate whether paracrine factors released from a synchronous neuronal 
population can diffuse to synchronize an asynchronous neural population and ii) with vertical 
perfusion, to compartmentalize the cell culture wells and investigate the astrocytes-mediated 
propagation of circadian rhythms among neural populations located in the wells. 
 
Figure 6: Microfluidic device, its fabrication and compartmentalization testing. A) View of a Si 
mold. Scale bar: 1 cm. B) View of a PDMS microfluidic device on a glass substrate. Each device is 
realized on a 4’’ wafer and provides 4 pairs of interconnected wells. Scale bar: 1 cm. C) 
Compartmentalization testing by using a Coomassie Brilliant Blue dye. Case without vertical perfusion 
(upper panel): as shown the blue dye in the left well can flow in the right well. Case with vertical 
perfusion (lower panel): as shown the blue dye remains confined in the left well. Scale bar: 0.5 cm. 
2.5.2 Paracrine factors-mediated neurons (N1)-to-neurons (N2) 
synchronization 
A possible way for the synchronization between neuronal populations relies on the release and 
diffusion of paracrine factors. In this case, a synchronous neuronal population may release 
paracrine factors that diffuse to the asynchronous neural population and synchronize it. To 
investigate this hypothesis, I used the microfluidic device without applying a vertical perfusion 
in the interconnecting channel, thus allowing a fluidic connectivity between the two wells and 
the diffusion of factors among the two neuronal populations.  
For these experiments, rat cortical neurons were plated on coverslips and cultured in 24-well 
dishes for 22-24 days in vitro (DIVs). As neurons in culture are asynchronous (Welsh et al., 
1995), they were synchronized with 100nM of Dexamethasone (Dexa) for 2h and placed 
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upside-down in one well of the device (N1), while coverslips with asynchronous neurons (N2) 
were placed in the other well of the device (Figure 7A). Both neuronal cultures were harvested 
at different time points, from 6 to 54 h after Dexa treatment, and the expression of the clock 
gene Bmal1 was analyzed by qPCR (Figure 7B). As expected, N1 is synchronous. Interestingly, 
results show that also N2 synchronizes, thus suggesting that paracrine factors released by a 
synchronous neural population are able to synchronize an asynchronous neural population. 
To confirm this result, I performed the same experiment but by blocking the fluidic connectivity 
between the wells. Having noted that a time window of 36 hours is enough to verify if a cell 
population is synchronous or not, this and next experiments were performed on an optimized 
time-window ranging from 6 to 36 h after Dexa treatment. As shown in Figure 7C, N1 is 
synchronous, with an increase in the amplitude compared with the previous experiment. This 
could be an effect induced by the continuous supply of medium used for the perfusion. 
Interestingly, under this condition N2 remains asynchronous, thus suggesting that paracrine 
factors released by N1 are necessary for its synchronization. Furthermore, this result further 
proofs that the microfluidic device works properly, and that the vertical perfusion is able to 
effectively compartmentalize the two chambers.  
In order to investigate what are the paracrine factors involved, I decided to start from the main 
neurotransmitters, i.e. glutamate and GABA. Two different experiments were performed, with 
a synchronous neural population (N1) in one chamber and an asynchronous neural population 
(N2) in the other one, in a condition of fluidic connectivity between the two chambers. In the 
first case, N2 was incubated with the NMDA receptor antagonist DQP1105 (50μM) (Figure 
7D); in the second case, N2 was incubated with the GABAA receptor antagonist Bicuculline 
(30μM) (Figure 7E). Results show that N2 synchronizes in presence of NMDA receptor 
antagonist, even if with a different amplitude, while it does not synchronize in presence of 
GABAA receptor antagonist, suggesting that for the paracrine factors-mediated synchronization 
between distant and segregated neuronal populations GABA but not glutamate is necessary. 





Figure 7: Synchronous neurons synchronize a segregated neuronal population via GABA 
signaling. A) Schematic illustration of the cell culture in the PDMS microfluidic device. N1=neurons 
synchronized with Dexamethasone (dexa) 100nM. N2=asynchronous neurons. B) Bmal1 expression in 
N1 and N2 in a condition of fluidic connectivity between the two chambers. C) Bmal1 expression in N1 
and N2 without fluidic connectivity between the two chambers. D) Bmal1 expression in N1 and N2 in 
a condition of fluidic connectivity between the two chambers and in presence of the NMDA receptor 
antagonist DQP1105 50μM in N2. E) Bmal1 expression in N1 and N2 in a condition of fluidic 
connectivity between the two chambers and in presence of the GABAA receptor antagonist Bicuculline 
(bic) 30μM in N2. Bmal1 was analyzed at the indicate time points by qPCR. All graphs show the mean 
± s.e.m. of the cosine-fitted curves from an experiment performed in triplicate.  
2.5.3 Astrocytes-mediated neurons (N1)-to-neurons (N2) synchronization  
As it is difficult to think that in the brain the synchronization among distant neuronal 
populations occurs only through the release of neuronal paracrine factors, and given the 
emerging role of astrocytes in neuronal synchronization, I hypothesized that these glial cells 
may act as a channel for the transmission of clock rhythms between two distant and segregated 
neuronal populations. Before experimentally investigate this hypothesis, I first assessed if the 
constant perfusion of cell culture media used to segregate the cell populations in the two wells 
might have effects on the expression profile of astrocytes clock genes. In order to do this, a 
monolayer of asynchronous astrocytes (i.e. not treated with Dexa), was plated in the 
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microfluidic device. Successively, astrocytes were harvest at different time points, before and 
during the perfusion, and the expression profile of the clock gene Bmal1 was analyzed by qPCR 
(Figure 8A).  
Results show the presence of a rhythmic expression of Bmal1 already before the perfusion. 
Most likely, this synchronization is induced by changes of the cell culture medium, an effect 
already reported by Prolo and colleagues (Prolo et al., 2005). Moreover, these data show the 
persistence of the rhythmicity during the perfusion, with an increase of Bmal1 expression but 
without a significant increase in the amplitude of the oscillation. The increase of Bmal1 
expression is attributable to the effect on astrocytes of B27, a serum-free culture supplement 
present in the medium used for the perfusion (Beaulé et al., 2009). Following experiments were 
implemented by considering this result.  
Next, I investigated whether astrocytes might define communication channels to transfer 
circadian rhythms to distant neural populations. First, cortical astrocytes were plated in the 
microchannel and in the two wells of the microfluidic device, while cortical neurons were plated 
on coverslips and cultured in 24-well dishes. Astrocytes and neurons were cultured separately. 
When astrocytes were confluent (3-4 DIVs) and neuronal cultures were at 22-24DIVs, the 
fluidic connectivity between the two chambers of the microfluidic device with cultured 
astrocytes was blocked. Then, neurons grown on coverslips were synchronized with 100nM of 
Dexa (2h) and placed upside-down on one well of the device (N1), while coverslips with 
asynchronous neurons (N2) were placed in the other well of the device. Under this condition, 
the only way of communication between the two populations of neurons was through astrocytes 
(Figure 8B-C). Upon cell harvesting, the expression of the clock gene Bmal1 was analyzed by 
qPCR (Figure 8D). Remarkably, results show a rhythmic expression of this clock gene in all 
populations, thus suggesting that astrocytes can transfer circadian information among different 
neuronal populations. 
These first experiments reveal that a synchronous population of neurons can transfer, through 
an astrocyte network, circadian information to a segregated neuronal population. Following 
these experimental results, to confirm that the cell culture media induced synchronization of 
astrocytes does not determines the N2 synchronization, I investigated what happens if both 
neuronal populations (N1 and N2) are initially asynchronous. To do so, I performed two 
experiments, by changing the cell culture medium in astrocytes 24h (Figure 8E) or 14h (Figure 
8F) before starting the co-culture. For the same reason described above, for this and next 
experiments with astrocytes I decided to reduce the time points analyzed, going from 6 to 36 h 
after Dexa treatment. Results show that astrocytes have a circadian rhythmicity of Bmal1, 
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whose phase changes according to the time the cell culture medium was changed. However, in 
both cases astrocytes are not able to synchronize any of the neuronal populations. This result 
suggests that media- and synchronous neurons-induced astrocyte synchronizations act 
differently, but also that the synchronization induced by the cell culture medium is not effective 
in synchronizing neurons. 
 
 
Figure 8: Astrocytes can transfer circadian information among distant and segregated neuronal 
populations. A) Left: Bmal1 expression in astrocytes before (blue) and with (orange) perfusion used to 
segregate the wells of the microfluidic device. Bmal1 was analyzed at the indicate time points by qPCR. 
The graph shows the mean ± s.e.m. from an experiment performed in triplicate. Right: Amplitude of 
Bmal1 oscillation in astrocytes before (blue) and with (orange) perfusion. Paired t-test: *P<0.05, 
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**P<0.01 and ***P<0.001 versus astrocytes before perfusion. B) Schematic illustration of the cell 
culture in the PDMS microfluidic device. N1=neurons synchronized with Dexa 100nM. 
N2=asynchronous neurons. A1,A2=asynchronous astrocytes. C) Optical micrograph of astrocytes plated 
in the channel of the microfluidic device. Scale bar: 50 µm.  D) Bmal1 expression in each cellular 
population (N1, A1, A2, N2). Only N1 was synchronized with Dexa 100nM. E) Bmal1 expression in 
each cellular population (N1, A1, A2, N2), with medium changed 24h before starting the experiment. 
N1,N2=asynchronous neurons. A1,A2=asynchronous astrocytes. F) Bmal1 expression in each cellular 
population (N1, A1, A2, N2), with medium changed 14h before starting the experiment. 
N1,N2=asynchronous neurons. A1,A2=asynchronous astrocytes. In D), E), F), Bmal1 was analyzed at 
the indicate time points by qPCR. All graphs show the mean ± s.e.m. of the cosine-fitted curves from 
an experiment performed in triplicate.  
In order to investigate the mechanisms involved in this astrocytes-mediated synchronization, I 
decided to divide all the process in three steps: ì) neurons (N1)-to-astrocytes (A1) 
synchronization; ìì) astrocytes (A1)-to-astrocytes (A2) synchronization; ììì) astrocytes (A2)-to-
neurons (N2) synchronization. These three components are studied individually in the next 
sections.   
2.5.3.1 Neurons (N1)-to-Astrocytes (A1) synchronization  
In the process of astrocytes-mediated synchronization, astrocytes receive “time” information 
from the synchronous neuronal population. Most likely neurons release factors which, by acting 
on astrocytes, initiate a signaling that is transmitted through astrocytes and then determines the 
synchronization of other neurons. To investigate what are the possible factors involved in the 
neurons-to-astrocytes synchronization, I decided to start from the two main neurotransmitters, 
glutamate and GABA. 
Astrocytes were plated in the channel and the wells of the microfluidic device (A1-A2), co-
cultured with asynchronous neurons placed in one well (N2) and treated with glutamate 400μM 
(20min) or GABA 100μM (2h) in the other well (A1). Both experiments were performed in a 
condition of fluidic connectivity blocked to ensure that the induced effects from one well to the 
other are mediated by cell-to-cell communication in the astrocytic network (Figure 9A). As 
shown in Figure 9C, neurons do synchronize in both cases, thus suggesting that the action of 
glutamate and GABA on astrocytes is required for the synchronization of a neuronal population. 
To confirm this result, three different experiments additionally were performed by using 
inhibitors of glutamate and GABA receptors. In this case, astrocytes were placed in the channel 
and the wells of the microfluidic device (A1-A2), a synchronous neural population (N1) in one 
well and an asynchronous neural population (N2) in the other one. The fluidic connectivity 
between the two chambers was blocked (Figure 9B).  
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To study the involvement of glutamate, A1 was incubated with the NMDA receptor antagonist 
DQP1105 (50μM) (Figure 9D) or with the AMPA/kainite receptor antagonist CNQX (10μM) 
(Figure 9E). Additionally, to study the involvement of GABA, A1 was incubated with the 
GABAA receptor antagonist Bicuculline (30μM) (Figure 9F). Results show that N2 remains 
asynchronous regardless of the inhibitors used, confirming that both glutamate and GABA are 
involved in the first step of the astrocytes-mediated synchronization observed between two 
segregated neuronal populations. Released by synchronous neurons, glutamate and GABA  act 
on astrocytes and trigger a cell-to-cell signaling that leads to the transmission of clock rhythms 
to a distant neuronal population. 
When released from synchronous neurons, glutamate and GABA bind their respective receptors 
on astrocytes, triggering a cascade of events. Indeed, it was shown that GABA activates 
astrocytes by binding to ionotropic GABAA receptor. This leads to glial calcium transients, 
which can induce the release of gliotransmitters, rendering GABA an important mediator of 
neuron-glia interactions (Nilsson et al., 1993; Meier et al., 2008; Mariotti et al., 2016). The 
same behavior was demonstrated for glutamate, which in astrocytes induces an intracellular 
calcium increase through the activation of NMDA and AMPA receptors (Zhang et al., 2003; 
Hu et al., 2004), induces calcium waves for a long-range signaling (Cornell-Bell et al., 1990; 
Kim et al., 1994) and upregulates gap-junctional communication (Rouach et al., 2000). There 
are also evidences indicating that the NMDA receptor in astrocytes could have a non-canonical 
metabotropic-like function, regulating Ca2+ exit from the endoplasmic reticulum and 
consequently increasing the intracellular calcium (Montes de Oca Balderas and Aguilera, 
2015).  
In light of this, knowing also that astrocytes synchronized by Dexa can synchronize neurons 
(Barca-Mayo et al., 2017) and that Dexa potentiates astrocytic signaling via long-range calcium 
waves (Simard et al., 1999), it is plausible to consider that glutamate and GABA released from 
synchronous neurons might act on astrocytes by determining an intracellular calcium increase 
and consequently an intercellular calcium signaling (ICS) that allows the transmission of 
circadian information to a distant neuronal population. Interestingly, it was also reported that 
the extent of the propagation of intercellular waves in astrocytes depends on the glutamate 
concentration: at low concentrations (< 1 µM), distinct areas of an astrocyte flickered 
asynchronously, and intracellular waves typically propagated only through portions of cells. At 
higher concentrations (1 to 10 µM), Ca2+i waves more commonly propagated through entire 
cells, and intracellular waves began to propagate into neighboring cells. At still higher 
concentrations (10 to 100 µM), intercellular waves began to propagate over long distances 
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(Cornell-Bell et al., 1990). This could explain why only astrocytes in contact with synchronous 
neurons are able to synchronize a distant neuronal population: differently from asynchronous 
neurons, synchronous neurons release factors in a circadian manner. Consequently, in certain 
period of time glutamate concentration is high enough to trigger the formation of calcium waves 
is astrocytes. This explanation would be in line also with the study of Ananthasubramaniam et 
al., showing that timing of coupling determines synchrony and entrainment in the mammalian 
circadian clock (Ananthasubramaniam et al., 2014). 
It has also to be noted that the increase of the astrocytic gap-junctional communication is not 
due to an upregulation of gap junction expression in astrocytes, as suggested by the analysis of 
the expression of Connexin43 (Cx43), the major astroglial Cx detected in cultured astrocytes 
(Giaume et al., 1991). For this, Cx43 expression was analyzed in A1 population of the two main 
experimental conditions, i.e. astrocytes in contact with synchronous neurons and astrocytes in 
contact with asynchronous neurons, and it does not show a significant difference (Figure 9G). 
This result is in line with other studies reported in literature where, in different experimental 
conditions, an increase of gap-junctional communication without an upregulation of Cx43 










Figure 9: Glutamate and GABA are involved in the first step of the astrocytes-mediated neuronal 
synchronization. A) Schematic illustration of the cell culture in the PDMS microfluidic device, with 
glutamate 400μM or GABA 100μM added in the left well. A1,A2=asynchronous astrocytes. 
N2=asynchronous neurons. B) Schematic illustration of the cell culture in the microfluidic device, with 
DQP1105 50μM, CNQX 10μM or Bicuculline 30μM added in the left well in order to block respectively 
glutamate and GABA receptors in astrocytes (A1). N1=neurons synchronized with Dexa 100nM. 
N2=asynchronous neurons. A1,A2=asynchronous astrocytes. C) Bmal1 expression in each cellular 
population in case of glutamate treatment (left panel) and GABA treatment (right panel). D) Bmal1 
expression in each cellular population, after blocking NMDA receptors with DQP1105 50μM in A1 
astrocyte population. E) Bmal1 expression in each cellular population, after blocking AMPA receptors 
with CNQX 10μM in A1 astrocyte population. F) Bmal1 expression in each cellular population, after 
blocking GABAA receptors with Bicuculline (bic) 30μM in A1 astrocyte population. G) qPCR analysis 
of Cx43 at different time points in astrocytes A1 in contact with asynchronous neurons (black) or 
synchronous neurons (gray). Paired t-test: *P<0.05, **P<0.01 and ***P<0.001 versus astrocytes in 
contact with asynchronous neurons. In B), D), E), F), Bmal1 was analyzed at the indicate time points by 




2.5.3.2 Astrocytes (A1)-to-Astrocytes (A2) synchronization  
To study the mechanisms involved in the transmission of circadian information through 
astrocytes, I first investigated whether the direct intercellular communication is required. To do 
so, I performed a synchronization assay under two different conditions: at first with astrocytes 
not in direct contact with each other, and secondly with astrocytes in direct contact. 
For the first condition (Figure 10A), the A1 astrocyte population was plated on coverslips (in 
12-well dishes) and grown until confluence. The A2 population was plated on 12-well dishes 
with paraffin feet that were successively used to avoid direct contact between the cultures (see 
Barca-Mayo et al., 2017). Astrocytes grown on coverslips (A1) were synchronized with 100nM 
of Dexa (2h) and placed upside-down in the dish containing the A2 astrocytes while sharing the 
same culture media. Then the A1 and A2 populations were harvested at different time points 
for subsequent analysis. For the second condition (Figure 10B), astrocytes were plated in the 
microfluidic channel and in the two wells of the microfluidic device. Once confluent, the fluidic 
connectivity between the two wells was blocked. Therefore, the only way of communication 
between the two populations of astrocytes was through astrocytes in the channel. Only one 
population (A1) was synchronized with 100nM of Dexa (2h). Finally, both A1 and A2 
populations were harvested at different time points and the expression of clock genes analyzed.  
For both conditions, the expression of the clock gene Bmal1 of A1 and A2 populations was 
analyzed by qPCR. Results show that synchronous astrocytes (A1) induce rhythmic expression 
of Bmal1 in previously asynchronous astrocytes (A2) only in the second condition, when the 
two populations are in direct contact. Therefore, our results reveal that astrocyte populations 
require their direct cellular interconnection to acquire clock rhythms, and that the closed 
proximity is not sufficient.  
Next, I aimed at investigating a possible mechanism that might be enabling this astrocyte-to-
astrocyte intercellular signaling of clock rhythms. It is well known that gap junctions mediate 
intercellular communication among cells by providing ultrastructural cytoplasmic continuity 
and that they are integral to formation of the functional syncytium of astrocytes (Bennett et al., 
2003). For this reason, I decided to block gap junctions, and in particular Cx43, the major 
astroglial connexin (Cx) detected in cultured astrocytes (Giaume et al., 1991). 
Therefore, I performed the same experiment described in Figure 8B, but under the condition of 
blocking hemichannels and gap junctions between astrocytes in the first or in the second well 
of the microfluidic device by using Gap26 (100μM). This compound is a mimetic peptide 
corresponding to a short linear sequence in the first extracellular loop of Cx43 (Desplantez et 
al., 2012; Li et al., 2015), which makes it specific for astrocytes.  
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Interestingly, results show (Figure 10C) that, under blockade of hemichannels and gap junctions 
in the A1 or A2 astrocyte population, the second neuronal population (N2) remains 
asynchronous and does not synchronize with the Dexa-treated N1 neuronal population. This 
result suggests that the intercellular communication between astrocytes through gap junctions 
is required for transmitting neuronal-clock rhythms among distant and segregated neuronal 
populations. 
Another important aspect for the astrocyte-to-astrocyte communication is the intercellular 
calcium signaling (ICS). Inositol trisphosphate (IP3) appears to be the best candidate to play 
the role of “fuel” in the propagation of ICS in astrocytes (Giaume and Venance, 1998). 
Therefore, to investigate if calcium signaling is required for the transmission of clock 
rhythmicity among astrocytes, I performed a synchronization assay in the microfluidic device, 
by incubating one astrocyte population (A1) with 2-APB (100μM, 2h), an IP3 receptor 
antagonist, in a condition of fluidic connectivity blocked (Figure 10D). Since 2-APB is not 
specific for astrocytes but blocks the release of calcium also in neurons, I did not used the N1 
neuronal population but synchronized directly A1 with Dexa 100nM. Results show that the 
neuronal population (N2) remains asynchronous, thus suggesting that the intercellular calcium 
signaling in astrocytes is required for the synchronization of distant neuronal populations. 
All these results support our hypothesis regarding the required glutamate-/GABA-induced 




Figure 10: Astrocytes require their direct intercellular communication to acquire and transmit 
clock rhythms. A) Schematic illustration of the astrocyte culture in the 12-well dishes used for 
experiment without cellular contact (left) and Bmal1 expression in both astrocyte populations (right). 
A1=astrocytes synchronized with Dexa 100nM. A2=asynchronous astrocytes. B) Schematic illustration 
of the astrocyte culture in the microfluidic device providing only cellular interconnections (left) and 
Bmal1 expression in both astrocyte populations (right). A1=astrocytes synchronized with Dexa 100nM. 
A2=asynchronous astrocytes. C) Bmal1 expression when intercellular communication between 
astrocytes is blocked with Gap26 100μM in A1 (left) or A2 (right). N1=neurons synchronized with Dexa 
100nM. N2=asynchronous neurons. A1,A2=asynchronous astrocytes. D) Bmal1 expression after 
blocking calcium signaling in A1 with 2-APB 100μM. A1=astrocytes synchronized with Dexa 100nM. 
A2=asynchronous astrocytes. N2=asynchronous neurons. In all graphs, Bmal1 was analyzed at the 
indicate time points by qPCR and the mean ± s.e.m. of the cosine-fitted curves from an experiment 
performed in triplicate is represented.  
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2.5.3.3 Astrocytes (A2)-to-Neurons (N2) synchronization  
The astrocytes-mediated transmission of clock rhythms from a synchronous to an asynchronous 
neuronal population, a signaling from astrocytes to neurons is necessary.  
In 2017, Barca-Mayo and colleagues demonstrated, by an experiment of co-culture with 
synchronous astrocytes and asynchronous neurons, that GABA, through GABAA receptor 
signaling, mediates astrocyte to neuron communication (Barca-Mayo et al, 2017). In the same 
year, in a demonstration of functional gliotransmission in the SCN, Brancaccio et al. showed 
that astrocytes release glutamate rhythmically and that blocking this release or uptake by dorsal 
SCN neurons suppressed and desynchronized circadian oscillations, suggesting a glutamatergic 
signaling between astrocytes and neurons (Brancaccio et al., 2017). Two years after, by two 
independent pharmacological approaches, i.e. interference with glutamate release by astrocytes 
(via Cx43 inhibition) and with neuronal glutamate sensing (via NMDA receptor antagonism), 
the same group demonstrated that glutamate is a necessary mediator of astrocytic control of 
circadian function in the SCN (Brancaccio et al., 2019).  
By taking these findings into consideration, I investigated on our microfluidic device whether 
both GABA and glutamate are involved in the astrocytes-to-neurons synchronization. To do so, 
I performed the same experiment described in Figure 8B, with astrocytes in the channel and the 
wells of the device, a synchronous neuronal population in one chamber and an asynchronous 
neuronal population in the other chamber, in a condition of fluidic connectivity blocked. In 
order to block NMDA receptors or GABAA receptors in the asynchronous neuronal population, 
I added DQP1105 50mM or Bicuculline 30μM respectively in the second chamber (Figure 
11A). As shown in Figure 11B-C, the N2 neuronal population remains asynchronous, thus 
confirming the involvement of both GABA and glutamate in the astrocytes-to-neurons 
communication of clock rhythms. 
42 
 
                     
Figure 11: Astrocytes synchronize neurons via a glutamatergic and GABAergic signaling. A) 
Schematic illustration of the cell culture in the microfluidic device, with DQP1105 50μM or Bicuculline 
30μM added in the right well in order to block respectively glutamate and GABA receptors in neurons 
(N2). N1=neurons synchronized with Dexa 100nM. N2= asynchronous neurons. A1, A2 = asynchronous 
astrocytes. B) Bmal1 expression in both neuronal populations (N1-N2) with glutamate receptors blocked 
in N2 with DQP1105 50μM. C) Bmal1 expression in both neuronal populations (N1-N2) with GABA 
receptors blocked in N2 with Bicuculline (bic) 30μM. In B) and C), Bmal1 was analyzed at the indicate 
time points by qPCR. All graphs show the mean ± s.e.m. of the cosine-fitted curves from an experiment 
performed in triplicate.  
2.5.4 Synchronization between neuronal populations at different distances 
So far, our experimental results revealed the presence of two pathways for the synchronization 
of distant and segregated neuronal populations: a neural paracrine factors-mediated 
synchronization and an astrocytes-mediated synchronization. 
To investigate if these two pathways may act regardless of the distance between neural 
populations, I performed specific experiments on microfluidic devices with an increased length 
of 10 and 17 mm channel, and that were realized by exploiting the flexibility of the established 
microfabrication process. With these devices I performed the same experiments that were 
previously reported in Figure 7A and 8B, both without and with astrocytes in the channel 
connecting the two neural populations.  
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Graphs of the qPCR data collected each 6 hours for 54 hours (Figure 12) show the expression 
of Bmal1 in the two neuronal populations in case of the “empty” channel condition, i.e. without 
astrocytes and only cell culture medium, and in the case of the channel with pre-seeded 
astrocytes used for studying astrocytes-mediated synchronization.  
As shown in panel A, paracrine factors released from a synchronous neuronal population are 
able to synchronize an asynchronous neuronal population at a distance of 10 mm, while not at 
a distance of 17 mm. For the case of the longer channel, the asynchronous neural population 
seems receiving an input for the synchronization but the neural population is not entrained over 
time. Differently, in the second condition shown in panel B, astrocytes are able to transmit 
neuronal clock rhythms also at the maximum distance of 17 mm, thus revealing the capacity of 
astrocytes to act as an active communication channel that can synchronize distant neural 
populations.  
It is important to highlight that in the first condition, paracrine factors released from the first 
neural population reach the second one primarily by diffusion through the channel. Thus, an 
increase in the length of the microchannel, leads to an increase of the time for a factor to diffuse 
to the second. Furthermore, a variation in concentration of a factor imposed in the first chamber 
over a certain time, leads to a variation in concentration in the second chamber that is distributed 
over a longer time. It has to be noted that the volume variation among the different devices due 
to the channel length is of 0.168 µl, and does not introduce significant variations in the 
concentration of paracrine factors among the different devices. Further, all these experiments, 
as previous ones, were performed with a fine control on the volumes of media and in triplicate. 
These considerations allow us to interpret the results of these experiments. Indeed, our data 
collected for the 17 mm long microchannel show that the second population receives an initial 
kick to start synchronizing, but, because of the microchannel fading over time of the variation 
in concentration of the paracrine factors released by the first neural population, this release of 
paracrine factors is not sufficient to entrain the synchronization. Interestingly, this also suggests 
that the entrainment of the second neural population requires continuous impulses of paracrine 
factors from the first population.  
Overall, the results of these experiments on different channel lengths reveal that neural 
populations can be entrained in synchronization through two pathways that could imply very 
different potential roles in brain circuits. Neuronal paracrine factors could be involved for local 
(or short-range) synchronization, while astrocytes can act as active communication channels to 






Figure 12: Astrocytes, but not neuronal paracrine factors, are able to transfer clock rhythms to 
longer distances. A) Bmal1 expression in both neuronal populations (N1,N2) in microfluidic devices 
with different lengths of the channel. Going from left to right, channel length is 3, 10 and 17 mm. Upper 
panels: case of paracrine factors-mediated synchronization, with channel “empty”, by means without 
astrocytes and with only cell culture medium. Lower panels: case of astrocytes-mediated 
synchronization. N1=neurons synchronized with Dexa 100nM. N2=asynchronous neurons. In all 
graphs, Bmal1 was analyzed at the indicate time points by qPCR and the mean ± s.e.m. of the cosine-
fitted curves from an experiment performed in triplicate is represented. B) Bmal1 expression in both 
astrocytes populations (A1,A2) in microfluidic devices with different lengths of the channel. Going from 
left to right, channel length is 3, 10 and 17 mm. A1,A2=asynchronous astrocytes. In all graphs, Bmal1 
was analyzed at the indicate time points by qPCR and the mean ± s.e.m. of the cosine-fitted curves from 





2.5.5 Effects of astrocyte reactivity on neuronal synchronization 
Alterations in the intercellular communication of astrocytes or in the expression of astrocytic 
clock genes contributes to the impairment of the neurobehavioral outputs, such as cognition, or 
to disorders associated with the timekeeping system (McKee et al., 2020). Based on this 
evidence, and knowing the important role of reactive astrocytes in brain diseases, I wondered 
whether the capabilities of astrocytes that I previously identified, to synchronize neuronal 
populations and to transfer molecular clocks among distant neuronal populations, are 
maintained by reactive astrocytes.  
Reactive astrogliosis is a term coined for the morphological and functional changes seen in 
astrocytes responding to CNS injury and other neurological diseases (Pekny and Pekna, 2014).   
A way to obtain reactive astrocytes is based on Tumor Necrosis Factor alpha (TNFα) 
treatments. TNFα is known to induce apoptosis in CNS and contributes to brain injuries in many 
neurological diseases. However, in contrast to neurons and oligodendrocytes, astrocytes 
exposed to TNFα do not show apoptosis and become reactive in response (Dietrich et al., 2003; 
Song et al., 2006; Zvalova et al., 2001). Moreover, TNFα was demonstrated to induce 
proliferation and viability in cultured astrocytes (Wang et al., 2018). In my experiments, I 
treated rat cortical astrocytes with TNFα 200ng/ml for 2h (Duhart et al. 2013). Such induced 
reactivity was confirmed by analyzing some of the major reactivity markers, such as GFAP, 
Serpina3n and Lcn2, whose expression level increases significantly after the treatment (Figure 
13A). By immunofluorescence analysis with an anti-cleaved caspase3 antibody, I also 
confirmed that the treatment with TNFα 200ng/ml does not induce apoptosis in cultured 
astrocytes (Figure 13B).  
To address the first question and investigate if reactive astrocytes are able to synchronize a 
neuronal population, co-culture experiments in single wells were performed. The well was 
seeded with astrocytes treated with TNFα and synchronized with Dexa, while an asynchronous 
neuronal population was placed in the same well and separated by paraffin feet. As shown in 
Figure 13C, the quantification of qPCR data collected from multiple preparations at different 
time points reveals that astrocytes seem to lose their capability to locally synchronize a neuronal 
population.  
To address the second question, and investigate if reactive astrocytes are still able to transfer 
circadian information to distant neuronal populations, I performed an experiment in the 
microfluidic device having astrocytes in both wells, reactive astrocytes only in the channel, a 
synchronous neuronal population in one chamber and an asynchronous neuronal population in 
the second chamber. Results obtained by fluidically segregating the two well populations 
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(Figure 13D) are reported in Figure 13E, and reveal how the asynchronous neuronal population 
can still get synchronized even in case of reactive astrocytes interconnecting the two chambers. 
This suggests that reactive astrocytes maintain their capability to transfer the required signaling 
for the synchronization of distant neuronal populations. However, this result is the consequence 
of an experiment performed just 24h after the treatment of astrocytes with TNFα. These 
astrocytes, therefore, can be considered in an acute-like phase of their reactivity. Ongoing 
experiments are targeting to investigate the same question also for a chronic-like phase of 
reactivity, as it can be obtained with longer treatments with TNFα. 
Despite being still preliminary, however, these first results highlight the possible link (so far 
demonstrated only for local synchronization) between reactive astrocytes and alteration of 
circadian rhythms. Consequently, this also suggests that it might be important to consider 
astrocytes as a cellular target for neuropharmacology studies on brain diseases involving 
transient or chronic perturbation of circadian rhythms.  
Figure 13: Role of reactive astrocytes for neuronal synchronization. A) qPCR analysis (mean ± sd) 
of GFAP, Serpina3n and Lcn2 in astrocytes treated with TNFα 200ng/ml and in astrocytes not treated 
(Ctrl). The experiment was performed in triplicate. Paired t-test: *P<0.05, **P<0.01 and ***P<0.001 
versus Ctrl. B) Representative immunofluorescence images of cultured astrocytes treated with TNFα 
200ng/ml or not treated (Ctrl), stained with anti-cleaved caspase3 (green). Nuclei are labelled with DAPI 
(blue). Scale bar: 50µm. C) Bmal1 expression in reactive astrocytes treated with Dexa 100nM (black) 
and in neurons (red) in a condition of co-culture in single well. D) Schematic illustration of the cell 
culture in the microfluidic device. Only astrocytes in the channel were treated with TNFα 200ng/ml for 
2h. N1=neurons synchronized with Dexa 100nM. N2=asynchronous neurons. A1, A2 = asynchronous 
astrocytes. E) Bmal1 expression in both neuronal populations (N1,N2) in the condition described in D). 
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In C) and E), Bmal1 was analyzed at the indicate time points by qPCR. All graphs show the mean ± 
s.e.m. of the cosine-fitted curves from an experiment performed in triplicate.  
2.6 Summary and Perspectives  
Circadian rhythms are essential in coordinating the proper timing of physiology and behavior 
(Hastings et al., 2003). The SCN of the hypothalamus is the master clock of the body and it is 
believed to control the body’s main circadian rhythm and communicate with peripheral brain 
and body regions about how and when to oscillate. What is unknown is how SCN neurons can 
transfer these information to distant neurons. 
In this work, by taking advantage of a microfluidic device developed in our laboratory, I 
investigated two possible hypotheses: i) a synchronous neuronal population might release 
paracrine factors for the synchronization of a distant neuronal population; ii) astrocytes might 
define communication channels to transfer circadian rhythms to distant neural populations. 
Results reveal that both pathways can occur. Indeed, synchronous neurons release paracrine 
factors that can diffuse and synchronize a distant, yet not too far, neuronal population. In 
particular, among the possible factors released by neurons, I found that GABA, but not 
glutamate, is necessary for the molecular clocks synchronization of a neuronal population 
through the binding of GABAA receptors. Glutamate, however, could have a role in determining 
the amplitude of the clock genes expression.  
Additionally, I also found that astrocytes can have a role in the transmission of circadian 
rhythms to distant neuronal populations.  Following this finding, I investigated the possible 
mechanisms that allow such transmission and synchronization, and divided this study in three 
steps: i) neurons-to-astrocytes synchronization; ii) astrocytes-to-astrocytes synchronization; iii) 
astrocytes-to-neurons synchronization. Results reveal that, in the first step, the synchronous 
neuronal population releases GABA and glutamate, which bind respectively GABAA receptors 
and AMPA or NMDA receptors on astrocytes. As suggested in literature (Hu et al., 2004; 
Mariotti et al., 2016; Meier et al., 2008; Montes de Oca Balderas et al. 2015), most likely this 
binding determines an increase in the intracellular concentration of Ca2+ leading to the 
formation of calcium waves that spread among astrocytes. In fact, blocking this spreading by 
using an IP3 receptor antagonist or a gap junctions blocker specific for astrocytes, I found that 
the distant neuronal population remains asynchronous. These results suggest that astrocyte gap 
junctions, and consequently the astroglial intercellular communication, and Ca2+ signaling are 
required for the transmission of the molecular clock synchronization to neurons. Of course, 
these findings do not exclude the involvement of ATP as another messenger for the spreading 
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of calcium waves among astrocytes (Fujii etr al., 2017; Guthrie et a al., 1999) and further 
analysis are needed to better understand the mechanisms involved in the transmission of 
molecular clock through astrocyte networks.  
Finally, concerning the astrocytes-to-neurons synchronization, my results show that both 
GABA and glutamate are involved. This is in line with the findings reported by Brancaccio 
(Brancaccio et al., 2017; Brancaccio et al., 2019) and Barca-Mayo (Barca-Mayo et al., 2017) in 
two different works, in which, by using different approaches, show that astrocytes can 
synchronize neurons respectively through a glutamate and GABA signaling.  
Based on these results, therefore, two mechanisms that allow the transmission of circadian 
information to distant neural clocks can be proposed (Figure 14): a paracrine factors-mediated 
synchronization through a GABA signaling, and an astrocytes-mediated synchronization with 
the involvement of both GABA and glutamate. Such two mechanisms can be complementary 
and ensure a robust synchronization of neuronal clocks in the brain.  
Further, our findings do not exclude the presence of other pathways or other molecules being 
involved. For example, in recent years it has become clear that neuropeptides are critically 
involved in the circadian timekeeping. One of such neuropeptide, the vasoactive intestinal 
peptide (VIP), was found to modulate molecular oscillations within individual oscillators, to 
synchronize individually oscillating neurons with each other and to synchronize SCN neurons 
with light cues (Vosko et al., 2007). Moreover, Marpegan et al. showed that VIP synchronizes 
and sustains rhythmicity in astrocytes in vitro, thus indicating that VIP can be a potent 
entrainment factor for cultured astrocytes. Importantly, this suggests that VIP might play a role 
as a neuron-to-glia coupling signal in vivo (Marpegan et al., 2009). Therefore, in future 
experiments that could use our microfluidic device, it will be interesting to investigate the 
possible role of neuropeptides in the transmission of molecular clocks among distant neuronal 
populations.  
Interestingly, by taking advantage of our microfluidic device, and by increasing the length of 
the channel, I found that paracrine factors-mediated synchronization occurs only on short 
distances, while astrocytes are able to transfer circadian information even at longer distances. 
This finding suggests the presence of at least two complementary mechanisms that could 
operate in parallel to ensure a robust synchronization of cellular clock in the whole brain. This 
is reasonable especially considering the limitations of diffusive paracrine factors to reach far 
neural populations in the brain. Therefore, in addition to indicate astrocytes as an “active 
channel” for the synchronization of distant neural clocks, my work strength the role of 




In perspective, the in vivo study of these two pathways and their implication in health and 
disease is a fascinating and original perspective for future studies.  
 
Figure 14: Mechanisms proposed for the synchronization of distant neuronal population. Two 
pathways have been identified in this work. A) Paracrine factors-mediated synchronization. Neurons 
release GABA that diffuses and, by binding GABAA receptors, trigger a signaling that allows the 
synchronization of neurons. B) Astrocytes-mediated synchronization. Neurons release GABA and 
glutamate, which bind respectively GABAA receptors and AMPA or NMDA receptors presents on 
astrocytes. This binding determines an increase in the intracellular concentration of Ca2+, triggering a 
calcium signaling (B.1). Through GAP junctions, calcium waves propagate in the astrocyte network 
(B.2). This signaling ends with the release of glutamate and GABA from astrocytes that, binding 
respectively NMDA and GABAA receptors on neurons, trigger the synchronization of neurons (B.3). 
A large amount of studies on mouse models have shown that astrocytes play a complex role in 
the pathogenesis of neurodegenerative diseases. The dysfunction of astrocytes may contribute 
to either neuronal death or the process of neural disturbances. Also, it has been found that 
reactive astrocytes always lose their supportive role and gain toxic function in the progression 
of neurodegenerative diseases (Li et al., 2019; Liddelow and Barres, 2017). It has to be noted 
that an alteration in the astrocyte intercellular communication or of astrocytic clock genes 
contributes to the impairment of neurobehavioral outputs, such as cognition, or to disorders 
associated with the timekeeping system (McKee et al., 2020).  
Based on these evidences, in my PhD I also started to investigate if reactive astrocytes maintain 
their capability to synchronize a neuronal population and to transfer molecular clocks among 
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distant neuronal populations. Preliminary results highlight that astrocyte reactivity does not 
impair the propagation of clock rhythms through astrocytes, but causes an impairment in the 
capacity of astrocytes to synchronize neuronal populations locally. This suggests a possible link 
between reactive astrocytes and alteration of circadian rhythms, but experiments on this topic 
are still in progress. 
Advancing in understanding the role of neuro-glia interactions in molecular clocks is a relevant 
topic for disorders linked to alterations in circadian rhythms, from mild disorders related to 
dysregulation of daily life to more sever pathologies. In perspective, this will undoubtedly lead 
to increasing the importance of considering astrocytes as a new cellular target for 
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3. Surface-functionalized self-standing 
microdevices exhibit predictive localization and 
seamless integration in 3D neural spheroids 
 
3.1 Abstract 
Three-dimensional (3D) brain models hold great potential for the generation of functional in 
vitro models to advance studies on human brain development, diseases and possible therapies. 
The routine exploitation of such models, however, is hindered by the lack of technologies to 
chronically monitor the activity of neural aggregates in three dimensions. A promising new 
approach consists in growing bio-artificial 3D brain model systems with seamless tissue-
integrated biosensing artificial microdevices. Such devices could provide a platform for in-
tissue sensing of diverse biologically relevant parameters. To date there is very little 
information on how to control the extracellular integration of such microscale devices into 
neuronal 3D cell aggregates.  
In this direction, in the present work I contributed to investigated the growth of hybrid 
neurospheroids obtained by the aggregation of silicon sham microchips (100x100x50µm3) with 
primary cortical cells. Interestingly, by coating microchips with different adhesion-promoting 
molecules, we reveal that surface functionalization can tune the integration and final 3D 
location of self-standing microdevices into neurospheroids. Morphological and functional 
characterization suggests that the presence of an integrated microdevice does not alter spheroid 
growth, cellular composition, nor network activity and maturation. Finally, we also demonstrate 
the feasibility of separating cells and microchips from formed hybrid neurospheroids for further 
single-cell analysis, and quantifications confirm an unaltered ratio of neurons and glia.  
These results uncover the potential of surface-engineered self-standing microdevices to grow 
untethered three-dimensional brain-tissue models with inbuilt bioelectronic sensors at 








The brain is one of the most complex and intriguing organs in humans, responsible for the 
advanced intellectual and cognitive ability. Although primates are capable of performing 
cognitive tasks, their abilities are less evolved. One of the reasons for this is the vast differences 
in the brain of humans compared to other mammals. Features that are unique to the human brain 
include its shape, large size and complexity.  
Unraveling the molecular and cellular mechanisms regulating brain development, as well as the 
evolutionary differences seen across species and the need to understand human brain disorders, 
are some of the reasons that make the study of human brain development fascinating and have 
attracted the attention of many scientists throughout centuries. 
However, our understanding of how human brain develops and functions is still very primitive. 
The main reason is that we cannot address these questions by studying the human brain itself. 
Indeed, the brain is formed largely in utero, and there are obvious important ethical 
considerations that limit access to the developing human brain. In addition, the brain, compared 
to tissues endowed with regenerative capacities, cannot be easily grown and expanded in the 
dish. Consequently, even the small live-tissue resections discarded from certain types of brain 
surgery make for very limited experimental platforms (Arlotta, 2018). 
For all these reasons, model systems are usually used to study the brain. Conventional models 
are standard in vitro two-dimensional (2D) cell cultures and in vivo animal models (Figure 15). 
2D cell cultures provide low cost and simplified approaches for studying the brain development 
and its diseases. Recently, pharmaceutical companies and research labs have enhances the 2D 
cell culture studies by utilizing human cells, including primary cells, embryonic stem cells, and 
induced pluripotent stem cells (iPSC). However, despite the progress on the availability of cells 
for 2D cultures, they fail to mimic the complexity of the human brain and its unique features 
and functions (Jorfi et al., 2018). First, cell-to-cell or cell-to-extracellular matrix interactions, 
which regulate important steps of neurodevelopment, are largely missing in a monolayer 
culture. Second, gradient of growth factors, patterning factors, nutrients, and gas exchange are 
critical for regional specification of the human brain, which is a challenge to model with a 
monolayer system. Third, a planar culture cannot recapitulate certain important cellular 
properties, such as cell polarity and guided cell migration (Koo et al., 2019). Moreover, 2D 
cultures cannot provide information regarding behavioral responses, many functional 
responses, or systemic responses (organ-organ interactions), and are therefore considered to be 
too simplistic for many practical applications (Nikolakopoulou et al., 2020). 
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Animal models, in turn, offer complexity but are often unable to recapitulate the human brain 
pathophysiology accurately and are associated with many specific interspecies differences. In 
addition, they are expensive, their throughput is low, and they raise ethical concerns.  
The lack of adequate models causes, for example, many drugs to fail in the transition from 
animal to human clinical trials. This has spurred academic and industrial researchers to seek 
out new technologies for mimicking brain physiology and functionality in health and disease, 
by using tools such as iPSCs, organ-on-a-chip (OoC) systems, organoids, 3D printed gels and 
neuronal machine interfaces. Though none of these methods can fully capture the complex 
physiology, anatomy and functionality of the human brain, they are nonetheless showing very 
promising results in terms of their capacity to recapitulate certain human functions or 
pathological mechanisms, as well as to reveal new physiological interactions that could not 
have been identified with current standard tools in vitro or in vivo (Nikolakopoulou et al., 2020). 
 
Figure 15: Schematic representation of available experimental models to study the human brain 
development and its diseases. This image was adapted from Jorfi et al., 2018. 
3.2.1 Mimicking the complexity of the human brain: 3D cellular models 
Over the last decade, there has been a dramatic effort to develop 3D in vitro brain models. This 
was mainly driven by the emergence of unprecedented enabling technologies, including stem 
cells, biomaterials and microfabrication techniques. These 3D physiologically relevant cell 
culture systems aim to closely mimic the human tissues and provide high-throughput and 
reproducible studies at molecular, cellular and circuit scales. The 3D cell-cell interactions and 
physiological cues provided by the extracellular matrix (ECM) tend to offer an in vivo-like 
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environment to cells. This is a core concept that has been applied for building 3D models of the 
central nervous system, such as brain-on-chips, neurospheroids and cerebral organoids. 
Nowadays, these 3D models offer a very powerful potential platform for understanding the 
human brain as well as for drug development and discovery in pharmaceutical industry for 
neurological diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), traumatic 
brain injury and related damage to the brain. Additionally, these experimental models could be 
invaluable test beds for assessing toxicology and the responses of the human brain cells and 
circuits to a variety of therapeutics (Jorfi et al., 2018). Here below I shortly introduce these 3D 
models by starting with organotypic brain slices, an experimental model that initially enabled 
several studies on brain circuits in vitro.  
3.2.1.1 Organotypic Brain Slice cultures 
Organotypic brain slice cultures (BSCs) have been the first attempt to bridge in vitro and in 
vivo models by creating a platform that resemble the brain in vivo environment while attempting 
to keep key in vitro characteristics (Shamir and Ewald, 2014; Humpel, 2015). These models 
now represent an established model for a variety of studies in neuroscience that can exploit 
them, for instance, with electrophysiology, immunohistochemistry and other techniques to dig 
into molecular, cellular and circuit level processes in health and disease.  
They are typically obtained from rodents but can also be obtained from human postmortem or 
biopsy brains (Humpel, 2015). 
The use of BSCs of postnatal rodent brain to model physiological and developmental properties 
was first established in the 1980s with the introduction of the roller-tube method (Gähwiler, 
1981). However, brain tissue cultured in this manner did not preserve the cytoarchitecture of 
the region of interest. To overcome this issue, in 1990s an alternative culture method referred 
as the interface-slice culture method, was introduced. This method is based on the properties of 
the air-liquid interface to drive nutrients inside the tissue and it involves culturing the tissue 
region of interest on a porous membrane interface between a humidified atmosphere and the 
culture medium. The explant of tissue attaches to the membrane and receives nutrition from the 
slice culture medium through the membrane via capillary action (Stoppini et al., 1991). The 
majority of BSCs are typically prepared from mice or rats up to postnatal day 12. At this age 
the cytoarchitecture is established, the brain is larger and easier to manipulate and neuronal 
cells are likely to survive the explantation (Bahr 1995). BSCs also display high levels of 
plasticity and therefore show resistance to the mechanical trauma incurred when neuronal 
processes are cut (De Simoni et al., 2003). 
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A main advantage of BSCs is that they retain a certain degree of the native 3D organization in 
culture, maintain vascular cells and are, at least partially, anatomically intact and representative 
of the area of which they are derived (Humpel, 2015; Hutter-Schimid et al., 2015). Neuronal 
and non-neuronal cells from the brain grown ex vivo in BSCs are representative of the 
populations found in vivo (Staal et al., 2011). This system therefore allows all cell types in the 
brain to be studied in a quite well anatomically preserved environment. A further advantage of 
this ex vivo system is that the development of cells and synapses mimics the development of 
the brain in vivo: neurons morphologically develop ex vivo as they do in vivo in acute 
preparations and retain similar synaptic connectivity, intact neuronal function and circuitry as 
observed in intact brain (De Simoni et al., 2003). Other advantages are the easy preparation, the 
low cost maintenance and the minimization of ethical issues compared to animal models 
(Shamir and Ewald, 2014). 
Organotypic brain models have been mainly used for assessing physiological and 
pharmacological properties of different tissues and for studying neurodegenerative disorders, 
serving as ex vivo models for diseases such as AD, PD, Huntington’s, and cerebral ischemia 
(Cavaliere et al., 2016; Croft et al., 2019). BSCs also represent a valuable platform for studying 
cell therapy approaches based on the grafting of engineered cells into slices and monitoring the 
induced effects. This allows researchers to assess cell-cell, and cell-cellular matrix interactions, 
cell migration, and stem cells phenotype changes (Daviaud et al., 2013).  
Despite all the advantages presented so far, organotypic brain slices also show key 
disadvantages that halted people from using them widely as a standard model. Indeed, these 
models can be maintained in cultures only for few weeks; they are very thin and fragile tissue 
(≈100–400 μm) and they can be distorted during the culture maintenance. Although organotypic 
slices derived from young animals (P3 to P10 – rats or mice) offer the most resilient slices, 
these slices do not represent a valuable model for adult neurodegenerative diseases (Jorfi et al., 
2019). 
3.2.1.2 Brain-on-a-Chip models 
The last decade has seen a growing trend towards engineering microphysiological systems 
(MPSs) called ‘organs-on-chip’. These are microfluidic-based microsystems capable of 
mimicking in vivo human physiology at small scale, reconstituting the key physiological 
elements and functions of different organs in a miniaturized and well-controlled 
microenvironment (Bhatia and Ingber, 2014; Jiang et al., 2014). Organ-on-chips can be used 
for a wide variety of applications such as drug discovery, personalized medicine or fundamental 
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research on cellular mechanisms. They accelerate pharmaceutical testing by harnessing the 
potential of microfluidic high-throughput technologies to lower cost, increase reproducibility, 
and speed up drug screening for adsorption, distribution, metabolism, excretion and toxicity 
compared to animal models that tend to be expensive and poor predictors (Guan et al., 2017). 
For all these reasons, organs-on-chip has already captured the attention of many pharmaceutical 
and medical companies as well as government regulatory agencies including the United States 
Food and Drug Administration (FDA). 
The MPSs offer the possibility of a 3D simulation also of the brain physiology and 
functionalities. The so called brain-on-a-chip has been a significant technological advancement 
in making human-relevant brain models for mimicking higher-order physiological and 
pathophysiological responses. They can be used to test the potential neurotoxicity of new drugs 
and to study the biochemical mechanisms underlying neurological disorders. Aside from ethical 
considerations, brain-on-chips overcome the high cost of animal care, the complexity of tissue 
isolation, the need for transgenic animals, as well as many of the uncertainties of translation of 
animal models to human physiology (Jorfi et al., 2019). The model reliability is strongly 
improved by using human-derived cells that are more relevant than animal models for 
pharmacological screening and disease studies. Patient-derived neurons from different regions 
of the brain can be directly grown and differentiated on a brain-on-a-chip device (Figure 16). 
The selected cells are capable of organizing themselves in the in vivo environment thanks to the 
device architecture, materials selection and bio-chemical functionalization (Miccoli et al., 
2018). In addition to this, brain-on-chips offer more control over the cell culture environment: 
the microfluidic channels connected to the cell culture microchamber allow continuous 
exchange of nutrients and growth factors along with discarding the waste, and the continuous 
flow ensures the cells get exposed to the nutrients equally (Jahromi et a., 2019).  
 
Figure 16: Concept representation of the growth of brain-on-chips starting from human-derived cells. 





3.2.1.3 Neurospheroids  
Neural cells can be cultured through self-assembly and without using scaffolds into spheroids 
structures, forming the so called neurospheroids. Spheroids have been employed to recapitulate 
the fundamental features of brain tissues in terms of cell diversity, electrophysiology, 
extracellular matrix (ECM) production and mechanical stiffness (Zhuang et al., 2017). 
Typically, these cellular aggregates secret their own ECM instead of requiring other foreign 
ECM-mimicking materials, hence, maintaining the native ECM composition.  
Dingle et al. generated 3D spheroids with rat neonatal cortical cells. Their 
immunohistochemical analysis revealed the presence not only of neurons, but also of multiple 
glial cell types, including astrocytes, oligodendrocytes, and even microglia. Remarkably, after 
14 days in vitro, patch-clamp recordings revealed that neurons were electrically active and 
participated in synaptic networks. In addition, such cortical spheroids secreted laminin and 
exhibited elastic modulus that was similar to that of newborn rat cortex (Dingle et al., 2015). 
Spheroid formation is one of the most well characterized models for 3D culture and screening 
due to its simplicity, reproducibility, and similarity to physiological tissues. Most importantly, 
spheroids can be monitored easily for practical daily observations. As a result, spheroid cultures 
have been valued as a physiologically relevant alternative to 2D cultures for decades (Tung et 
al., 2011) and are widely used for assays on non-brain tissues.  
Typical spheroid formation methods include hanging drops on the underside of culture plate 
lids, culture of cells on non-adherent surfaces, spinner flask cultures, and rotary cell culture 
systems (Del Duca et al., 2004; Friedrich et al., 2007). These traditional spheroid formation and 
culture systems, however, are often tedious, produce variable size spheroids, low-throughput, 
and hard to handle (Tung et al., 2011). To increase spheroid formation efficiency, offer better 
control of spheroid sizes, as well as simplify handling procedures, various microfluidic 
(spheroids on a chip) devices have also been developed (Torisawa et al., 2007; Sakai and 
Nakazawa, 2007; Torisawa et al., 2007; Wu et al., 2008).  
Using spheroid models, researchers have drawn great insights into tumor development and 
neurotoxicity (Ivanov et al., 2014; Avci et al., 2015; Terrasso et al., 2015). In addition, thanks 
to the possibility to obtain neurospheroids with neural progenitor cells, which are self-renewing 
multipotent cells that have the capacity to differentiate into neurons as well as glial cells, the 
neurosphere culture system has gained a great importance in studies investigating 
differentiation, neurotoxicological studies, and biological studies of developmental processes 
(Khan et al., 2018). Moreover, in recent years spheroids have been extended to model 
degenerative neurological diseases such as AD (Choi et al., 2013) and PD (Simao et al., 2015). 
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However, despite of the potentials in using neurospheroids, the major issue with this kind of 
culture is its sensitivity to the variable culture methods. This has made it difficult to formulate 
a unified culture procedure and therefore it has been difficult to merge discoveries from 
different groups to gain a complete understanding of a particular phenomenon (Khan et al., 
2018).  
3.2.1.4 Brain organoids 
Brain organoids are organ-like 3D tissue cultures derived from hPSCs that self-assemble to 
form an organized architecture, composed of progenitor, neuronal and glial cell types, 
resembling the fetal human brain (Jo et al., 2016; Lancaster et al., 2013; Pasca et al., 2015). 
They have been demonstrated to capture some fundamental features of human brain: not only 
brain organoids recapitulate the human brain at the cellular level, but also in terms of general 
tissue structure and developmental trajectory, providing in this way a unique opportunity to 
model human brain development and function (Qian et al., 2019) (Figure 17).  
In general, two different types of methodologies can be used to generate brain organoids. These 
are the so called “unguided methods” and “guided methods”.  
Unguided methods harness the intrinsic signaling and self-organization capacities of hPSCs to 
differentiate spontaneously into tissues mimicking the developing brain. In the protocol 
developed by the Knoblich group, embryoid bodies (EBs) derived from hPSC aggregates were 
embedded into an extracellular matrix (ECM), such as Matrigel, and subsequently cultured in 
spinning bioreactors to promote tissue expansion and neural differentiation (Lancaster and 
Knoblich, 2014). Cerebral organoids produced by this approach exhibit a variety of cell lineage 
identities ranging from forebrain, midbrain and hindbrain, to retina, choroid plexus and 
mesoderm (Camp et al., 2015; Lancaster et al., 2013). The stochastic nature of hPSC 
spontaneous differentiation, however, results in unpredictable proportions and a heterogeneous 
arrangement of each lineage and cell type across batches of differentiated organoids and across 
hPSC lines. Although this cell-type diversity in cerebral organoids offers a unique opportunity 
to model the interactions between different brain regions, the high variability and heterogeneity 
present significant challenges for systematic and quantitative studies (Qian et al., 2019). 
In “guided” organoid, small molecules and growth factors are used throughout the 
differentiation process to instruct hPSCs to form cells and tissues representative of certain brain 
regions (Jo et al., 2016; Pasca et al., 2015; Sakaguchi et al., 2015; Yoon et al., 2019). For 
example, a hindbrain neural tube-like structure that differentiates to form cerebellum-like 
organoids was generated by the sequential addition of FGF19 and SDF1 (Muguruma et al., 
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2015). These directed organoid cultures are sometimes capable of generating mixtures of cell 
types with relatively consistent proportions, exhibiting less variation across batches and cell 
lines (Sloan et al., 2017). However, directed organoids typically contain relatively small 
neuroepithelial structures and their cytoarchitecture is sometimes not well-defined, possibly 
owing to the interference of hPSC self-organization and cell-cell interactions by excessive use 
of external factors. 
The number and combination of external factors used in differentiation protocols varies, and 
the choice between unguided and guided approaches is often seen as a trade-off between 
diversity and consistency and will depend on the specific focus of investigation. For instance, 
unguided organoids are suitable for exploring cell-type diversity during whole-brain 
development, while brain region-specific organoids better recapitulate brain cytoarchitecture 
with less heterogeneity (Qian et al., 2019). 
Although cerebral organoid methods can produce tissues resembling various interacting brain 
regions, their proportion and spatial organization are highly heterogeneous and unpredictable. 
To improve modeling of inter-regional interactions, several groups concurrently developed new 
approaches, first differentiating hPSCs into different brain region-specific organoids separately, 
and then fusing them together to form organoids with multiple distinct region identities in a 
controlled manner (Bagley et al., 2017; Birey et al., 2017; Xiang et al., 2017). These fused 
organoids are called assembloids, a term coined by S. Paşca to describe the anatomical and 
functional assembly of multiple organoids (or spheroids), wherein infiltrating nerve fiber 
branching among two or more masses mimics interconnected brain areas (Paşca, 2018). 
Assembloids are a unique means to study the development of interconnections among brain 
areas in a controlled setting. Therefore, they carry the tremendous potential of enabling the 
replication (and characterization) of interconnected brain areas at the highest level of 
complexity so far witnessed in the tissue bioengineering field (Marton and Paşca, 2020; Forro 




Figure 17: Brain organoids derived from human pluripotent stem cells. A) Brain organoids enable 
a better understanding of human brain development and of the impact of genetic variation on brain 
development and function (Arlotta, 2018). B) Culture of whole-brain organoids (left) and dorsally 
patterned forebrain organoids (right) (Velasco et al., 2019). C) Sectioning and immunohistochemistry 
of a cerebral organoid (Lancaster et al., 2013). 
The brain organoid system is a highly accessible and genetically modifiable model by which to 
study the gene expression program during human brain development (Koo et al., 2019). Indeed, 
comprehensive transcriptome comparisons between forebrain organoids and the human fetal 
cortex at different stages showed that organoid development is reminiscent of fetal human brain 
development at the transcriptome level (Marton et al., 2019; Qian et al., 2016). Moreover, the 
profiles of the N6-methyladenosine (m6A) modification on mRNA from forebrain organoids 
and the human fetal cortex showed significant overlap, suggesting that the epitranscriptome 
landscape during human brain development is well recapitulated by brain organoids (Yoon et 
al., 2017a).  
Over the last few years, brain organoids derived from hPSCs, especially patient-derived iPSCs, 
have been widely used to model and investigate neurodevelopmental brain disorders (Arlotta, 
2018; Chen et al., 2018; Di Matteo et al., 2020; Klaus et al., 2019; Kyrousi and Cappello, 2020). 
The mechanisms of such disorders are frequently attributed to disrupted progenitor cell 
regulation, including premature differentiation, reduced proliferation, and cell cycle disruption, 
all of which can be analyzed reliably in brain organoids.  
Brain organoids have also attracted great interest as neurodegenerative disease models, but 
attempts so far have had limited success (Arber et al., 2017; Gonzalez et al., 2018). Because 
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most neurodegenerative diseases are late onset and age related, brain organoids mimicking 
embryonic brain development may not robustly reproduce disease-relevant endophenotypes. 
Brain organoids have been used also in cancer studies: they provide an accessible, scalable, and 
easily manipulable system to understand the progression and the resistance of cancer and to 
screen anti-cancer drugs with patient-derived samples (Hubert et al., 2016; Linkous et al., 
2019). 
These so promising model, however, suffer from several limitations. Firstly, they are extremely 
variable in size and shape. In addition, as the composition of Matrigel is not completely 
understood, many organoids that involve the use of Matrigel appear to be unstable and suffer 
from batch to batch inconsistency. This in turn restricts their use in high throughput screenings. 
Moreover, necrosis has been observed in most studies due to insufficient nutrient/oxygen 
exchange in the center of these structures. Thus, proper vascularization that integrates capillary 
networks into the organoid structures may be necessary to facilitate gas and nutrient exchange 
(Zhuang et al., 2018). 
3.2.3 Challenges of 3D cellular models  
Although 3D cellular models faithfully recapitulate a number of key features of the human 
brain, they are not perfect replica, and several biological and technical challenges need to be 
overcome in order to greatly expand our ability to investigate human brain development and 
disorders. 
3.2.2.1 Biological challenges  
The design and creation of these complex 3D cellular systems is not a simple process, and 
different biological limitations hinder the formation of an “ideal” model. 
The small size of current 3D models remains the fundamental limiting factor that prohibits from 
using them to fully recapitulate late stages of human brain development. Because of the lack of 
vascular cells and so of a circulation system with blood vessels, the viable thickness is restricted 
by the physical distance over which oxygen and nutrients can diffuse from the surface, which 
is typically less than 400 μm (Rambani et al., 2009). When culturing occurs over a long period, 
a substantial number of cells undergo apoptosis. Moreover, because neural progenitor cells 
(NPCs) with high metabolic demands are often located in the most interior part of the cortical 
structures, they are the first to succumb to the diffusion limit, and neurogenesis cannot be 
sustained in long-term cultures. The formation of a cortical plate with six distinct layers and 
cortical folding is therefore still out of reach (Qian et al., 2019). Methods to create a more 
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permissive environment to alleviate this condition include the use of spinning bioreactors or 
orbital shakers to enhance diffusion (Kadoshima et al., 2013; Lancaster et al., 2017; Qian et al., 
2016). Recently, a blood vessel organoid was successfully generated from human PSCs, 
containing endothelial cells and pericytes that self-assemble into capillary networks. Human 
blood vessel organoids can be transplanted into mice to form a stable, perfused vascular tree, 
including arteries, arterioles and venules (Wimmer et al., 2019). In the future, human brain 
organoid technology could be combined together with a blood vessel organoid to establish a 
functional closed circulation system, to support long-term culture and to study neurovascular 
interactions. Another promising approach for long-term culture is the transplantation of 
organoids into animals, allowing the host vasculature to grow into the organoid graft (Mansour 
et al., 2018). Alternatively, the incorporation of biomaterials and microfluidic systems could be 
used to engineer vascular-like networks with perfusion to supply the organoid interior with 
adequate oxygen and nutrients (Qian et al., 2019).  
Another important biological challenge is the differentiation into various cell types: the brain 
consists of so many different cell types (different kind of neurons, astrocytes, oligodendrocytes, 
microglia, pericytes, and endothelial cells) that need to be present in precise ratio and have 
substantial cell–cell interactions to reach organ functionality (Pamies et al., 2014).   
In addition, variability, consistency and reproducibility in cell types should be considered 
carefully to perform fine quantitative studies and large-scale unbiased screening. Over the last 
few years, researchers have been working on protocols for 3D cultures with minimal variability, 
mainly focusing on homogenizing morphologies. By using single cell RNA-seq, a study of 
Yoon et al. highlighted that multiple human cortical spheroids showed similar cell-type 
composition and proportions (Yoon et al., 2019). In the same year, single-cell RNA-seq analysis 
revealed that dorsal forebrain organoids derived from different stem cell lines showed 
consistent cell-type composition after three months or six months. The developmental 
trajectories of cells in different batches of organoids were also consistent and reproducible, and 
dorsal organoids had transcriptomic profile similar to that of a human fetal cortex (Velasco et 
al., 2019). 
Lastly, the fact that 3D cellular models dynamically mimic the temporal progression of human 
brain development is both an advantage and a disadvantage for researchers. On the one hand, 
3D cellular systems of different ages recapitulate their corresponding in vivo counterparts, 
offering researchers a versatile platform to probe different developmental stages. On the other 
hand, from a practical point of view, these models take a long time to grow and mature, raising 
the cost and hindering the efficiency of experiments (Qian et al., 2019). Methods for speeding 
72 
 
up the maturation process, or to parallel the growth of organoids in a highly reproducible way, 
thus need to be advanced. 
3.2.2.2 Technological challenges  
The routine experimental use of 3D brain tissue models remains largely unpractical also 
because of several technological limitations.  
First of all, 3D brain models are more difficult to evaluate than traditional monolayer cultures, 
which are normally more easily accessible. Studies are largely confined to cell morphology 
assessments, and barely extend to the evaluation of physiological functions of cells. Available 
biosensing technologies, developed for 2D cultures, are not yet adapted for the routine 
monitoring of biosignals such as neural activity or physiological paramters inside individual 
3D models. This hinders studies aiming towards a better understanding of the emergence of 
spontaneous neural activity in these models as well as the optimization of culture methods and 
protocols to reliably generate electrically active brain-tissue models for functional assays.  
Current functional analysis of 3D models most commonly relies on optical technologies, such 
as calcium imaging, as overall screening technique of the tissue functionality (Aleksandra et 
al., 2014). However, these approaches are limited to measures on the superficial outer layer of 
the sample, without the possibility to resolve in detail the 3D network dynamics, and are subject 
to alignment issues, which makes them unpractical to study large number of samples. 
Electrophysiology techniques so far used to study 3D models function are patch-clamp and 
multielectrode arrays (MEAs) recording. Patch-clamp has been used to address the presence of 
Na+ and K+ currents involved in action potential dynamics, the firing properties of neurons, as 
well as to address the presence of excitatory and inhibitory synaptic activity (Birey et al., 2017; 
Sakaguchi et al., 2015; Trujillo et al., 2019; Xu et al., 2016; Logan et al., 2010). In this regard, 
however, the available information remains qualitative, whereas a quantitative analysis as well 
as a direct comparison with the native brain structure of reference is yet to be completed. 
Similarly as 2D neural cultures, 3D cultures can grow on top of biosensing devices, such as 
MEAs for multisite extracellular electrophysiology with planar or protruding electrode 
morphologies. These devices comprise passive MEAs with a few tens of individually 
electrically wired microelectrodes, as well as more recent generations of monolithic active 
multielectrode arrays realized in complementary metal-oxide semiconductor technology 
(CMOS-MEAs) with on-chip front-end and multiplexing circuits to continuously monitor 
extracellular neural activity from several thousands of closely spaced microelectrodes (Heer et 
al., 2004; Frey et al., 2007; Berdondini et al., 2001; Berdondini et al., 2009). MEA recording 
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not only allows detailed network dynamics studies of the 3D tissue, but it also enables a direct 
comparison with the human brain electrical patterns (Trujillo et al., 2019; Fair et al., 2020). 
However, this approach requires that each 3D cell culture model grows on a dedicated 
biosensing device, thus challenging the development of low-cost consumable biosensing chips 
and constraining sample number. Another technical limitation of such tool is in achieving a 
good electrical contact between the electrodes and the tissue, as the latter does not offer a flat 
surface that can optimally adhere to the planar MEA substrate. To overcome this issue, two 
main approaches may be considered: sample processing and recording device. In terms of 
sample processing, one strategy consists of letting the intact tissue sit on the MEA, previously 
coated with adhesion-promoting  molecules typically used in neuronal culture and that have no 
interference with recording capabilities (poly-(d)-lysine, poly(l)-ornithine, laminin) (Amin et 
al., 2016). However, such procedure could induce cell spreading and organoid disaggregation, 
and the recorded signal might as well represent the result of a secondary 2D network activity 
established upon guidance by the coating biomolecule. The other strategy could consist of 
slicing the tissue to obtain thin (200-300 µm) sections. In this way, it is possible to get access 
to the inner tissue layers and bypass its surface, which most frequently contains not electrically 
active stem cells (Qian et al., 2020). The negative aspect of this approach is that it does not 
preserve the original 3D circuitry in full, whereas, ideally, electrophysiological measurements 
should be performed on the intact tissue assembly in order to obtain a global picture of its 
network dynamics. In terms of recording devices for organoids, silicon array probes inserted 
directly into the intact tissue sample have been successfully employed to overcome the technical 
limitations posed by planar MEA (Quadrato et al., 2017). Silicon probes enable recording local 
field potentials, as well as single- and multi-unit activity, with the added advantage of enabling 
a depth electrophysiology profile of the bioengineered brain tissue. The invasiveness of these 
implantable devices and consequent tissue-damage, however, leads to low yield electrical read-
outs and restricts measures to acute (non-chronic) experimental conditions. 
In the light of the limitation of current technologies, a promising alternative approach to 
overcome these issues consists in the development of bio-artificial 3D brain model systems 
with seamless tissue-integrated biosensing artificial microdevices, without perturbing 3D 
model in terms of development, morphology, composition and functionality. Optically-
interfaced self-standing microscopic silicon particle devices internalized in cells (Gomez-
Martinez et al., 2010) or even in embryos (Fernandez-Rosas et al., 2010) were proposed. These 
micrometric intracellular devices were demonstrated for tasks such as cell tracking using a 
barcode system (Fernandez-Rosas et al., 2009), intracellular pressure sensing (Gomez-Martinez 
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et al., 2013) or to implement multistage delivery systems (Tasciotti et al., 2019). However, 
because of alignment and light scattering issues, the functional performances of these very small 
area optically-interfaced devices were demonstrated so far only on isolated cells or 2D cell 
cultures.  
On the other hand, a new class of extracellular tissue-integrated microdevices might be 
developed by exploiting recent achievements in the massive downscaling of free-floating 
microelectronic independent biosensor nodes down to 10-100 µm in size (Angotzi et al., 2019). 
Such extracellular CMOS-based microdevices, or “neural dusts”, would allow label-free 
routine electrophysiological measures from the inside of each self-standing 3D model, such as 
spheroids or complex brain organoids. So far, neural dusts were proposed for stable chronic 
brain machine interfaces in vivo and are meant to communicate neural data back to an 
interrogator by modulating the amplitude, frequency, and/or phase of an incoming ultrasound 
wave (Neely et al., 2018; Seo et al., 2013). Early proof-of-concepts report electroneurograms 
(ENG) obtained with a single neural dust mote anchored to the sciatic nerve of an anesthetized 
rat (Seo et al., 2016). Other studies used commercial radio frequency identification (RFID) 
chips of 460 x 480 µm2 in size integrated into re-aggregated iPSC-derived endoderm spheroids 
to demonstrate phenotypic screenings of a pool of RFID-modified organoids (Kimura et al., 
2018). Finally, McDonald et al., with inspiration from implantable mesh electronics and growth 
of organoids on polymer scaffolds, proposed the fabrication of suspended hammock-like mesh 
microelectrode arrays for neural organoids (McDonald et al., 2020). 
Recently, at IIT we proposed a circuit architecture for large-scale radiofrequency (RF) based, 
low-power active CMOS microdevices (100 x 100 µm2) providing integrated circuits for 
extracellular sensing of neural activity in organoids (Angotzi et al., 2018). While bioelectronic 
and wireless technologies to realize such microdevices are under study, to date there is very 
little information on how to integrate extracellular Si microchips into neuronal 3D cell 
aggregates. Further, the potential impact of extracellular Si microdevices on cell viability, 3D 








3.3 Aim  
Three-dimensional (3D) neural cell assemblies are rapidly emerging as more comprehensive in 
vitro model systems of the brain tissue to study neurological diseases and for next-generation 
screening assays in drug-discovery. However, despite remarkable recent progresses, 
establishing and applying such models is hindered by the lack of technologies to chronically 
monitor the activity of neural aggregates in three dimensions.  
A promising new approach consists in self-standing biosensing microdevices capable of 
achieving seamless tissue integration during cell aggregation and in vitro culture. 
Recently, we proposed a circuit architecture for large-scale radiofrequency (RF) based, low-
power active complementary metal-oxide semiconductor (CMOS) microdevices 
(100x100x50µm3) providing integrated circuits for extracellular sensing of neural activity in 
organoids (Angotzi et al., 2018) (Figure 18). These dimensions were chosen so that 
microdevices would be smaller than a typical rat cortical spheroid (typically 200-300 µm in 
diameter at 21 days in vitro (Dingle et al., 2015)), yet large enough to integrate all the required 
circuits for wireless biosensing (Angotzi et al., 2018; Burke et al., 2010; Seo et al., 2015).  
Figure 18: Perspective of the developing technology. Functional description of a prototypical lab-on-
chip platform application in which bionic organoids are individually guided along a micro-fluidic 
channel toward a recording base integrating a µPort device for RF wireless powering and data readout 
from µRadios fused into 3D human brain organoids (left); block diagram of the µPort and of the CMOS 
µRadio devices (right). This image was adopted from Angotzi et al., 2018. 
While bioelectronic and wireless technologies to realize such microdevices are under study, to 
date there is very little information on how to integrate extracellular Si microchips into neuronal 
3D cell aggregates. Further, the potential effects of aggregating artificial Si microdevices with 
cells on cell viability, 3D morphology and network functionality are still unexplored.  
To address these questions, in this work I contributed to this development by investigating the 
3D assembling of neurons with microfabricated Si sham devices, and the growth of bio-artificial 
hybrid spheroids from rat primary cortical neurons.  
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3.4 Materials and methods 
3.4.1 Silicon microchip fabrication 
The fabrication of Si microchips requires standard microelectronic processes (Figure 19A). 
First, squares of 100 x 100 µm² of 100 nm sputtered aluminum were patterned via lift-off 
(Microchem S1813 photoresist) onto an N-type 50µm silicon wafer (Si-Mat) and acted as a 
mask for the silicon etching step (Figure 19A-1). The thin silicon wafer was then transferred 
onto a thicker substrate by means of a dissolvable glue (Xtal bond SPI 555, Figure 19A-2). A 
standard Bosch process at 5°C allowed to etch through the 50 µm-thick wafer (ICP-RIE Si 500, 
SE Tech instruments) (Figure 19A-3). 
3.4.2 Silicon microchip surface modifications 
3.4.2.1 (3-aminopropyl)triethoxysilane (APTES) 
Following this step, both SiO2 (10 nm) and (3-aminopropyl)triethoxysilane (APTES, 40 cycles, 
dose 30”) were deposited through atomic layer deposition (FlexAL, Oxford Instruments) onto 
the substrate (Figure 19A-4). Finally, the microchips were released in deionized water in a glass 
vial. To avoid having molten glue residues in the vial, the deionized water was cold (4°C) and 
a gentle ultrasound was applied on the vial for a few seconds to completely release the small 
silicon microchips into the vial (Figure 19A-5). The microchips were then rinsed twice in 
deionized water before being sterilized under hood UV for 1 hour (Figure 19A-6). 
3.4.2.2 Protein coatings 
For each trial, the microchips were separated in different sterile vials. For protein 
immobilization, water was replaced with either 800µl of poly-DL-ornithine (0.1 mg ml-1, Sigma 
P0671), poly-D-lysine (0.1 mg ml-1, Sigma P6407) or Matrigel (0.5%, Corning 354230), and 
incubated overnight at 37°C and 5% CO2. The next day, the vials were rinsed three times with 
sterile Milli-Q water. In the end, one vial per condition was obtained: microchips without 
coating (No coat.), microchips with Matrigel coating (MG), microchips with PDL coating 
(PDL) and microchips with PDLO coating (PDLO).  
3.4.3 Characterization of the coating-induced wettability 
To characterize surface wettability and their stability over time, water droplet contact angle 
measurements were performed onto macro pieces of silicon using Dataphysics OCAH200 
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contact angle instrument equipped with a 2/3’’ CCD Chip camera. Four inches silicon wafers 
type N 500µm were cleaned in piranha for 2 min (1:3 H2SO4:H2O2, Sigma Aldrich), then 
subjected to the same surface modifications as described above. The wafers were then cut in 8 
and kept in dry box. For each time point, one piece for each condition was retrieved, blown 
under nitrogen flow and 5 contact angle measurements were made using 5µL droplets of 
deionized water. 
3.4.4 Spheroids formation 
All animal procedures carried out in this work were approved by the institutional IIT Ethics 
Committee and by the Italian Ministry of Health and Animal Care (Authorization No. 
110/2014-PR of the 19th of December 2014). 
Primary neuronal spheroids were established from cerebral cortices of Embryonic day 18 (E18) 
Sprague–Dawley rats and maintained at 37°C in a humidified atmosphere of 5% CO2. The 
following solutions and media were used: Hanks Balanced Salt Solution (HBSS) (Sigma 
H6648); digestion solution  ̶  Trypsin (0.125%, Thermo Fisher Scientific 25050014) in HBSS 
+ DNase (0.25 mg ml-1, Sigma D5025) in HBSS 5mM CaCl2; complete Neurobasal medium 
(NB, Thermo Fisher Scientific 21103049) supplemented with B27 (2%, Thermo Fisher 
Scientific 17504044), Glutamax (1%, Thermo Fisher Scientific  35050038) and 
Penicillin/Streptomycin (1%, Sigma P4333); FBS (Sigma F7524). Briefly, embryos were 
removed and decapitated, brains were extracted from the skulls and placed in cold HBSS. After 
dissection, cortices were placed in the digestion solution and incubated in water bath at 37°C 
for 30 minutes. Few milliliters of complete NB + FBS (10%) were added to the cell solution, 
centrifuged at 1200 rpm for 5 min, and the supernatant was removed. The cell pellet was 
resuspended in fresh complete NB +  FBS (10%) and gently pipetted for no more than 10 times 
with P1000 pipette. The solution was filtered with a cell strainer (Biologix 15-1040, 40µm pore 
size), centrifuged at 700 rpm for 7 min, and the supernatant was removed. The cell pellet was 
resuspended in complete NB. Cell viability at the time of isolation was determined by a Trypan 
Blue Exclusion Assay (Sigma T8154). Cortical cells were then seeded at a density of 6500 cells 
in 75µL medium in ultra-low attachment plates (GravityTRAP ULA plate 96-wells). In order 
to avoid bubbles in the wells, first 25µL of warm NB was plated in the wells, then the plate was 
centrifuged at 250g for 2 minutes, before adding 6500 cells in 50µL in each well. Following 
cell plating, silicon microchips were seeded by carefully pipetting 1µL of water in each glass 
vial, visually inspecting that it contained only one device, before plating it one by one in the 
wells. For each condition (control, µchip with and without protein), a minimum of 24 wells 
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were plated. Device-less wells were re-plated after inspection. After a few hours, the plates 
were centrifuged at 250g for 2 minutes before being kept in incubator for 21 days. At DIV 5, 
10, 14 and 19, the medium was partially replaced with 30µL of fresh complete NB. 
3.4.5 Morphology assessment 
3.4.5.1 Optical microscopy 
At DIV 3, 5, 7 10, 14, 17 and 21, plates were retrieved from the incubator and images were 
taken from all wells using a Leica DMI 6000 B inverted microscope with a x10 objective. At 
each time point, the circularity of the spheroids, its area therefore its mean radius and the 
distance between the center of the device compared to the centroid of the spheroid were 
measured using ImageJ software (Schneider et al., 2012). Contaminated wells, dirty wells 
(residues) and wells containing more than 1 device, were not taken into account in the 
morphology assessment. They represented approximately 8-15% of all wells. Besides, at early 
time points, wells containing more than one single spheroid were also excluded. Overall, 
between 13 and 23 wells were considered at each time point for each condition and each trial 
(3 distinct trials, at different time during the year and with distinct animal dissection). 
3.4.5.2 Scanning electron microscopy (SEM) 
At DIV5, 10, 14, 17 and 21, six spheroids per condition (Ctrl, No Coat., MG, PDL, PDLO) 
were fixed in paraformaldehyde (PFA, 2% v/v, Santa Cruz Biotechnology 30525-89-4) and 
glutaraldehyde (GA, 2% v/v, Sigma G5882) in phosphate-buffered saline (PBS) (Thermo 
Fisher Scientific 10010056) for 2 hours, followed by three washes in PBS. The samples were 
post-fixed in osmium tetroxide (1%) in Milli-Q water for 2h and washed with Milli-Q water. 
The spheroids were subsequently dehydrated with a series of 10min incubations in rising 
concentrations of ethanol in water solutions (from 30% to 100%), 1:1 
ethanol:hexamethyldisilazane (HMDS, Sigma-Aldrich) and HMDS (100%) and dried 
overnight in air.  Finally, the samples were sputtered with Au (10 nm) and analyzed by SEM 
(FEI NanoLab 600 dual beam system). 
3.4.5.3 Immunofluorescence imaging and analysis 
At DIV5 and DIV21, a few spheroids from each condition were fixed in PFA (2%) and GA 
(2%) (see previous section). All the following steps were performed on a shaker at 4°C. The 
following antibodies were used: mouse anti-tubulin β3 (BioLegend 801213, 1:50), rabbit anti-
glial fibrillary acidic protein (GFAP, DAKO Z0334, 1:250), Alexa488 goat anti-rabbit 
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(Invitrogen A11034, 1:200) and Alexa647 goat anti-mouse (Invitrogen A21236, 1:200). 
Spheroids were permeabilized and blocked with Triton X-100 (TX, 1%, Sigma T9284), normal 
goat serum (NGS, 10%, Sigma G9023), and bovine serum albumin (BSA, 4%, Sigma A9647) 
in PBS (B-PBT) for 2h, and subsequently incubated in primary antibodies diluted in B-PBT 
overnight. Spheroids underwent two 2-h washes with TX (0.2%) in PBS (PBT), followed by 
one 2-h B-PBT wash. Spheroids were incubated with secondary antibodies in B-PBT overnight. 
Spheroids underwent two 2-h PBT washes and were incubated with Hoechst (BD Biosciences 
561908, 1:300) in PBT for 1 h and returned to PBS. Spheroids were kept in PBS and transferred 
to glass-bottomed confocal dishes for imaging. All images were acquired with 40x objective 
lenses using a Leica SP5 inverted confocal microscope (Leica Microsystems). For each 
condition, the maximum intensity projection of a Z-stack from approximately half spheroid 
(from the bottom to the maximum diameter) is displayed. 
3.4.6 Neural activity assessment 
Calcium dye Fluo-4 AM (ThermoFisher 14201) was reconstituted in Dimethyl Sulfoxide 
(DMSO) according to manufacturer’s instructions. Spheroids were incubated with Fluo-4 AM 
at the final concentration of 2.5 µg ml-1 in extracellular saline solution (HEPES 10mM, D-
Glucose 5.5mM, NaCl 145mM, KCl 5mM, CaCl2 2mM, MgSO4 1mM, pH 7.3-7.4) and 
incubated at 37°C in the dark for 15 minutes. Spheroids were consequently washed twice in 
extracellular saline solution and transferred in 300 µl of the latter in a chamber with glass 
bottom for live imaging. Live imaging was performed with inverted confocal microscope Nikon 
A1 coupled with a Nikon Objective 20X Plan Apo A.N.0.75 (Nikon Instruments S.p.A.), using 
a 488nm laser for the green fluorescent dye. The focus plane was made on top of the spheroid, 
and the pinhole adjusted so that each manually-selected regions of interest (ROI, 5µm in 
diameter) could be reasonably be associated as the contribution of a single soma in the spheroid. 
Each recording session lasted 10 minutes and consisted of 8 minutes of unperturbed activity, 
followed by injection of KCl (2mM) to activate voltage-gated calcium channels and depolarize 
the cells. Fluorescence intensity from various regions of interest (ROI) was then exported from 
Nikon imaging software NIS 5.02 (Nikon Instruments S.p.A.) and analyzed with OriginLab. 
For each ROI, the linear decrease in fluorescent intensity due to bleaching was compensated, 






 versus time was plotted, where 𝐹0 represents the mean ROI baseline 
intensity when no activity is detected, after bleaching compensation. An event is defined by the 
sudden increase and decrease of fluorescent intensity over 3 times the noise standard deviation; 
a ROI is defined active if more than 2 events occur during the recording sessions. For each 
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recorded spheroid, the average number of active ROI on the focus plane considered was 
counted. Spheroids with less than 3 active ROI or for which the KCl control did not have a 
depolarization effect, were not considered. 
3.4.7 Single-cell analysis by Fluorescence-Activated Cell Sorting (FACS) 
Spheroids at DIV28 were desegregated with the Papain Dissociation System (Worthington 
Biochemical, LK003150) according to the manufacturer’s instructions. Briefly, 156 spheroids 
per condition were pooled in a tube (one tube per condition), washed with PBS and placed in 
the papain solution (20 units/ml papain, 0.005% DNase). The tube was incubated at 37°C with 
constant agitation (550 rpm) for 1h. Every 10 minutes, spheroids were triturated with P200 
pipette and the solution re-equilibrated with 95% O2:5% CO2. After 1h, while the freed devices 
remained at the bottom of the tube, the single cell suspension was transferred to a new tube and 
centrifuged at 300g for 5 min at room temperature. The pelleted cells were resuspended in 
albumin-inhibitor solution with DNase (according to the manufacturer’s instructions) and 
centrifuged at 1200 rpm for 5 min. For FACS analysis, the pelleted cells were fixed in PFA 
(4%) for 20 min at room temperature, washed and centrifuged at 1200 rpm for 5 min. The 
pelleted cells were permeabilized with Triton X-100 (0.05%) in PBS for 20 min at room 
temperature, washed with cold FACS buffer (0.05% Triton X-100 and 0.5% BSA in PBS) and 
centrifuged at 1200 rpm for 5 min. The pelleted cells were stained with mouse anti-Neuronal 
Nuclei (NeuN, Alexa Fluor 488 conjugated, Millipore MAB377X, 1:1000) and mouse anti-
GFAP (Alexa Fluor 647 conjugated, BD Pharmigen 561470, 1:250) in FACS buffer for 30 min 
on ice in the dark. Cells were washed, centrifuged at 1200 rpm for 5 min and resuspended in 
200µl of FACS buffer. FACS analysis was performed with BD FACSAria™ III cytometer (BD 
Biosciences), at least 10000 events for each dot plot were acquired and data were analyzed with 
CellQuest™ software.  
3.4.8 Data processing and statistical analysis 
Data processing and analysis was performed by considering: 
1. Pre-processing of data (e.g., transformation, normalization, evaluation of outliers): For 
cell culture analysis, wells excluded from the study were: dirty wells (residues, 
contamination), wells containing more than 1 device, wells containing more than one 
single spheroid 24h after seeding. 
2. Data presentation (e.g., mean ± SD): Droplet contact angle: mean ± SD. 
Circularity and spheroid radius: mean ± SEM (standard error of the mean). 
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Internalization degree: mean ± SD. For FACS analysis, percentage of gated events 
compared to total events is represented. 
3. Sample size for each statistical analysis: a) Droplet contact angle: n=5 per surface 
treatment and per time point. b) Circularity, mean spheroid radius and internalization 
degree: 3 trials were performed (1 trial = set of 21 DIV-long cultures from 1 sacrificed 
animal, at different times during the year), with for each trial 24 wells dedicated per 
surface treatment. Without excluded wells (contaminated etc. see previously), we have 
n=[13,23] for each data point represented. c) FACS: 1 trial with 156 spheroids per 
condition and at least 10000 events acquired for each dot plot. 
Data analysis was performed using the following softwares: Matlab, OriginLab, 



















3.5 Results and discussion 
3.5.1 Formation of hybrid neurospheroids from spontaneous aggregation of 
neurons and Si microchips  
In this work, we first fabricated silicon dummy microchips (or µchips) to study their 
aggregation with primary neuronal cells and the growth of bio-artificial hybrid neurospheroids.  
The fabrication process of these generic Si microchips is depicted in Figure 19A and detailed 
in the “Materials and Methods” section. This rather simple process includes a single 
photolithography and a step of deep reactive ion etching (DRIE) of the 50 µm thick Si substrate. 
It results in the production of approximately 2000 microchips of dimensions 100x100x50 µm3 
per cm². Once structured, devices were top-side coated with a layer of silicon dioxide (SiO2) 
and of (3-aminopropyl)triethoxysilane (APTES) through atomic layer deposition processes 
(ALD).  
The deposition of SiO2 underneath ensures that the squares sides, covered in fluorinated 
residues from the DRIE process, are then well coated with the same material all over the µchips, 
on which APTES can bond more uniformly. In this way, ALD deposition provides a conformal, 
repeatable, uniform layer on the silicon µchips surface.  
The APTES was shown to stabilize protein immobilization on different substrates, including 
silicon, silicon dioxide and polydimethylsiloxane (PDMS), which in turn supports adhesion and 
long-term viability of neuronal and glial cells in cell cultures (Gunda et al., 2014; Kuddannaya 
et al., 2015). In order to handle microchips for the successive steps, devices were finally 
released in deionized water and sterilized under hood UV for 1 hour. 
To investigate whether surface functionalization of the device can promote aggregation of cells 
around the microchips, I tested three different adhesion-promoting molecules typically used in 
neural cultures and that have shown no interference with recording capabilities (Amin et al., 
2016), namely Matrigel (MG), Poly-D-lysine (PDL) and Poly-DL-ornithine (PDLO). MG is a 
solubilized basement membrane matrix, mainly containing extracellular matrix (ECM) 
components such as laminin, collagen I and entactin (Laplaca et al., 2010), and widely used as 
a biologically active embedding scaffold suitable for 3D neural cell culture (Lancaster et al., 
2013; Meseke et al., 2012; Kunze et al., 2011). PDL and PDLO are also routinely used to 
promote adhesion and differentiation of primary neurons on glass or Si substrates through an 
increase of surface charge density (Harnett et al., 2007; Yavin et al., 1974). These three 
molecules can bind onto the APTES layer, as evidenced by the contact angle measured on clean 
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SiO2 surfaces (Figure 19B). The APTES coating on SiO2 surfaces increases the contact angle 
from 7.85° to 47.1°, a value in line with APTES deposition from aqueous solutions 
(Kuddannaya et al., 2015). Matrigel binding increases slightly the surface hydrophobicity to 
60.2°, which is to be expected for a gel-like structure while PDL and PDLO significantly 
decrease the contact angle to 11.2° and 13.6° respectively. As evidenced by the contact angle 
measured at different times over 28 days (Figure 19C), the presence of amine-terminated silanes 
after APTES deposition allows for proteins to covalently bind on the surface, which in turn 
provides a stable interface over time (Cargill et al., 1999; Kim et al., 2011). 
This is an important pre-requisite for future applications in organoid development, where 
cultures are maintained for extended periods (over 9 months) (Quadrato end Arlotta, 2017). 
As illustrated in Figure 19D, primary cortical neurons prepared from rats at embryonic day 18 
(E18) were seeded in ultra-low attachment 96-well plates and added with single Si microchips 
in each well. Despite involving different coatings on the devices and steps of manual 
manipulation of cells and microchips, this protocol reliably yielded bio-artificial 3D 
neurospheroids (between 78-87% for n=4 trials and over 96 plated wells per trial). As a step 
forward, production could be automated and scaled up by using pick-and-place and microfluidic 
techniques. 
 
Figure 19: Aggregating bio-artificial hybrid neurospheroids with Si microchips. A. Schematic 
representation of generic microchip fabrication and SEM images of the realized Si devices. 1) Lift-off 
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of Al 100nm on an N-type 50µm-thick Si wafer. 2) Transfer of the wafer onto a thicker substrate by 
means of a water-dissolvable glue. 3) Standard Bosch process etching the whole 50µm-thick Si wafer. 
4) ALD deposition of 10nm of SiO2 and of a layer of APTES. 5) Release of the microchips in deionized 
water using a US bath and 6) Sterilization under UV light. B. Mean and standard deviation (SD) of 
contact angle measurements on Si substrates with different coatings (n=5). C. Mean and SD of contact 
angle measurements on Si substrates with different coatings at different time points. Overall, all protein 
immobilizations appear stable over time. n=5 per surface treatment and per time point. D. Schematic 
representation of the aggregating protocol and microscopy images of cells and devices at DIV0 and after 
the aggregation of a hybrid spheroid at DIV21. Primary cortical neurons from rat embryo were cultured 
in ultra-low attachment plate along with a 100x100x50µm3 microchip previously functionalized with 
adhesion-promoting coatings. Scale bar 200µm. 
3.5.2 Morphology of developing hybrid neurospheroids 
The morphology of developing neurospheroids aggregated with differently coated microchips 
was characterized by optical microscopy imaging at multiple time-points and over 21 days of 
in vitro culture (DIV). These results provide an overall initial evaluation of whether the 
presence of the Si microchip might affect spheroid growth and its roundness. As shown in 
Figure 20, the quantification of the circularity and the mean radius does not reveal major 
differences among developing spheroids with and without microchips (see Figure 20C for an 
example), neither among spheroids integrating microchips with different coatings. Spheroids 
form and maintain a circular shape (circularity ratio > 0.84 after 3 DIVs) and grow progressively 
over the course of 3 weeks, reaching a plateau in their mean radius at around 14 DIVs, 
corresponding to approximately 500 µm in diameter. The dimensional increase observed 
between 3-14 DIVs (about 200 µm in diameter) is most likely due to an increase of the inter-
cellular spacing which mainly results from network formation and astrocyte proliferation 
(Dingle et al., 2015). Slight inter-trial differences (Figure 21) are most likely due to variations 
in the ratio of astrocytes and neurons among primary cell culture preparations.  
Overall, these results indicate that neither the presence of the microchip nor its functionalization 
affects the spheroid growth and its roundness, suggesting that the device does not disrupt the 




Figure 20: Morphology of bio-artificial 
hybrid neurospheroids. A. Spheroid 
circularity (mean ± SEM) and B. spheroid 
radius (mean ± SEM) of neurospheroids 
without microchip (Ctrl) or with differently 
functionalized microchips (No coating, 
MG, PDL, PDLO) as measured in 2D by 
optical contrast images. No major 
difference in the radius and circularity of 
spheroids is to be noted, neither between 
conditions with and without microchip, nor 
between the different coatings used. 
Depending on condition and time point, 
n=[13-23]. C. Examples of these optical 
micrographs showing the aggregation and 
spheroid formation in the absence and 
presence of a microchip (in this case, coated 
with PDLO) at DIV0, DIV5 and DIV21 















Figure 21: Inter-trial variability of neurospheroids circularity and radius. Both the circularity and 
the radius (mean+SEM) of neurospheroids without (Ctrl) and with microchip (No coating, MG, PDL, 
PDLO) are represented at different time points from DIV3 to DIV21. The size of spheroids varies from 
one trial to another throughout the time points, suggesting that the difference in spheroids dimensions 
results more from a difference in the number of cells plated (errors in cell counting, diverse proportion 
of astrocytes between neuronal preparations), than the speed of growth of the spheroids. Besides, from 
DIV7 on, all spheroids have a circularity above 0.9 for all conditions, approaching an ideal sphere as 
time goes. Depending on condition and time point, n=[13-23]. 
3.5.3 Surface functionalization of Si microchip determines its location inside 
neurospheroids 
To investigate the extent of the Si microchip integration in the forming neurospheroid, optical 
microscopy imaging of the wells was used over 3 weeks. To quantify this integration, we 
defined a parameter, the internalization degree (𝐼𝐷), corresponding to the ratio between the 
distance from the spheroid center to the microchip center 𝐷𝑠𝑝ℎ−𝑡𝑜−µ𝑐ℎ𝑖𝑝, and the radius of the 





An ID between 0 and 75% corresponds to the case where the microchip is located in the center 
of the spheroid; an ID between 75% and 125% to the case where the microchip is located in the 
periphery of the spheroid; while an ID above 125% indicates that the microchip is not integrated 





Figure 22: Phase-contrast analysis of neurospheroids with different levels of microchip 
integration. Three examples of phase-contrast image analysis taken at DIV21, in the case of an 
internalization degree (ID) of the microchip of i) 148% ii) 87% and iii)31%, corresponding to a 
microchip outside the spheroid, on the periphery and inside the spheroid, respectively. 
In Figure 23 I report the internalization degree quantified for each condition (No coat., MG, 
PDL and PDLO) in the case of one representative experimental trial (see Figure 24 for all other 
trials). Results show a marked difference in the microchip integration depending on the 
functionalization used. Microchips without any coating (red) tend to remain on the surface of 
the spheroid and in some cases (between 12% and 33%, all trials and all time points included) 
they are not even in contact with the spheroid. This suggests the presence of a weak adhesion 
of the microchip that might have detached upon handling of the multiwell plate. In the case of 
Matrigel coating (blue), the majority of microchips, particularly from DIV14 to DIV21, is 
integrated in the inner part of the periphery of the spheroids, suggesting a much stronger 
interaction between cells and microchips. Finally, in the case of PDL and PDLO (green and 
yellow, respectively), the vast majority (between 65 and 100%, for all trials and all time points) 




Figure 23: Internalization degree of the microchip inside neurospheroids. The ID (mean ± SD) is 
defined here as the inclusion ratio between the distance center-of-spheroid to center-of-microchip and 
the corresponding spheroid radius. As such, a microchip on the external part of the spheroid would have 
an ID of 75-125%, while a microchip in the spheroid center is represented with an ID close to 0%. Data 
points are represented for different surface functionalizations during 21 DIVs.  Depending on condition 




Figure 24: Inter-trial variability of the internalization degree. ID (mean ± SD) of microchips 
without (no coat) and with functionalization (MG, PDL, PDLO) into neurospheroids is represented. 
Overall, the different trials show very similar trends. Without coating, the microchip remains on the 
periphery of the spheroids or is not in contact with the spheroid in the well. With Matrigel coating, the 
majority of the microchips remain on the periphery of the spheroid, but as time goes, get internalized a 
little more, suggesting a highest coupling between the cells and the microchip. With PDL and PDLO, 
the microchip is internalized from early time points on, with an ID generally below 75%. Data points 
are represented. Depending on condition and time point, n=[13-23]. 
These results reveal the important role of the surface chemical properties of the microchips for 
the 3D assembling and growth of bio-artificial hybrid neural constructs. Since these results were 
obtained by quantifying parameters computed from the planar projection of the 3D spheroid in 
the well, I qualitatively verified them by scanning electron microscopy (SEM), which allows 
direct 3D visualization of the spheroids with microchips. Figure 25 displays representative 
examples of spheroids at different developmental time points for different functionalization 
conditions. These 3D micrographs confirm optical imaging results on the different levels of 
microchip integration depending on the surface functionalization. In particular, uncoated Si 
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microchips remain on the external surface of the spheroid, with a few neurites holding the 
device in place. This leads to a weak integration of the microchip into the spheroids and to a 
high number of devices detaching from the spheroid. Matrigel-coated microchips remain on the 
periphery of the spheroid, but exhibit more neurites that keep the device in place, which in turn 
supports a stronger interaction. Finally, for PDL and PDLO conditions, SEM images display 
much more neurite growth on the microchip at early time points and a higher level of microchip 
integration: at 21 DIV it is barely possible to distinguish the presence of the device in the 
neurospheroid. 
 
Figure 25: 3D inclusion of microchip in neurospheroids. SEM micrographs of fixed neurospheroids 
taken at different time points, without microchip (Ctrl) and with microchip, depending on the protein 
used on the microchip surface (No coating, MG, PDL and PDLO). When the microchip is either not 
coated (APTES) or coated with Matrigel (MG), it remains on the periphery of the spheroid, while as 
time goes, the spheroid englobes the microchip when the latter is coated with either PDL or PDLO. 




These results indicate that surface functionalization allows to control the assembly of 3D bio-
artificial neuronal constructs with different levels of in-tissue integrated self-standing micro-
devices. Controlling the microdevice position in the 3D neural aggregate is particularly relevant 
for brain organoids. For instance, a microdevice with pH sensing capabilities internalized in the 
center of brain organoid would allow routinely monitoring the diffusion of nutrients and oxygen 
to detect the formation of a necrotic core, which in turn would provide crucial information to 
optimize organoid cultures efficiency (Jorfi et al., 2018). Besides, being able to control the 
placement of microdevices at different locations inside organoids would provide access to 
different cellular layers to routinely monitor neural activity or the chemical microenvironment, 
thus overcoming limitations of current imaging techniques for high-throughput read-outs. 
3.5.4 Neuronal and astrocytic cell composition of hybrid neurospheroids 
Using immunofluorescence analysis of neuronal and glial markers, I further investigated 
whether the presence of Si microchips might affect spheroids cellular composition. 
Neurospheroids at DIV5 and DIV21 from each condition were fixed, stained and analyzed 
through confocal microscopy (Figure 26). At DIV5, spheroids exhibit globular patterns of β-
III-tubulin neuronal staining (red), and fewer GFAP-positive (Glial Fibrillary Acidic Protein) 
astrocytes (green), while cells are highly packed in the structure, as evidenced by Hoechst 
staining (blue). At DIV21, both neurons and astrocytes express more elongated neurites, 
bundles, and form a complex network, while the distance between nuclei increases under the 
effect of astrocyte proliferation and neurite extension complexity. No evident difference is 
observed in the composition and maturation of the network with respect to the presence of the 
microchip, independently of the coating used. These qualitative imaging data suggest that the 
Si microchip does not alter astrocyte proliferation, neurite branching nor the overall 
development of 3D neural constructs. As already observed, the position of the microchip highly 
depends on the coating used. Without adhesion-promoting protein (No coat.), the microchip 
remains on the periphery of the spheroid, with few neuronal branching keeping the microchip 
in place, and actually often losing it (9 times out of 10 the microchip is lost during the 
immunostaining process). With Matrigel (MG), the microchip remains on the periphery but is 
much more well-retained by both neuron and astrocyte branching. For both PDL and PDLO, 
the microchip is covered by dendrites as early at DIV5, and cell nuclei eventually migrate over 






Figure 26: Fluorescence imaging of cortical spheroids with and without microchip. Confocal 
projections at DIV5 (upper panel) and DIV21 (lower panel) of spheroids reveal the presence of CNS 
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(Central Nervous System) cell types, including neurons (β-III-tubulin, red) and astrocytes (GFAP, glial 
fibrillary acidic protein, green). Nuclei are labeled with Hoechst (blue). Images are merged with and 
without bright field (BF). Data show a proliferation of neuronal connection between DIV5 and DIV21, 
and a great increase in GFAP-expressing astrocytes in the network in a similar fashion between 
spheroids with and without microchips. Scale bar 50µm. 
3.5.5 Expression of spontaneous neural activity in hybrid neurospheroids   
The integration of Si microchips might affect the expression of spontaneous neural activity. To 
verify this, I used calcium dye confocal microscopy imaging and compared the developmental 
activity in control spheroids without microchips with bio-artificial hybrid spheroids. Given the 
little influence of coatings observed on neurospheroid cellular composition, only PDL-coated 
devices were used. After one week in culture and throughout three weeks, Ca2+ oscillations 
represented as fluorescent variations are detected (Figure 27A-C). The pharmacologically-
induced KCl depolarization confirms that this calcium activity is associated with neuronal 
activity. At DIV7, neurospheroids both with and without microchips exhibit signs of neuronal 
activity on a few regions of interest (ROI). At this stage of development, the activity is sparse, 
both spatially and temporally, and no synchronous activity is detected (Figure 27A). Upon 
network development, at DIV14, all spheroids exhibit more active ROIs, with in some cases 
the appearance of synchronous activity among distant ROIs (Figure 27B). After three weeks, 
neurospheroids tend to express a sustained spontaneous activity both in terms of numbers of 
active soma as well as in the frequency of spikes (Figure 27C). Figure 13D shows that the 
number of active ROIs for each tested spheroid increases over developmental time, and very 
similar activity levels are observed between control spheroids and spheroids containing a 
microdevice. This suggests that the presence of the Si microchips does not perturb the 
spontaneous functional development of neurospheroids over the observed experimental time 
window of three weeks. 
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Figure 27: Calcium imaging frequency response of cortical neurons. Neurospheroids activity was 
measured using fluorescence indicators (Fluo-4 AM) of intracellular calcium oscillations. The 
fluorescence intensity displays representative activity during 8-10min of recording neurospheroids with 
and without microchip during development. A. After one week in culture, a few soma from the focus 
plane start exhibiting activity. B. After two weeks in culture, spheroids display single spikes from 
neurons, with in some cases synchronous activity among distant ROIs (region of interest). C. After three 
weeks in culture, spheroids with and without microchip exhibit synchronous spontaneous neural activity 
among many ROIs. Injection of 2mM KCl was used as a control. D. Graphs representing the level of 
activity exhibited from calcium imaging from spheroids at DIV7, DIV14 and DIV21, with or without 
the microchip. The bars correspond to the number of spheroids that exhibited either between 3 and 10 
active ROI, or more than 10 active ROI in the focus plane. Only samples where KCl control was positive 
were considered. The results show that in both cases (with or without microchip), the level of maturation 
of spheroids is similar: spheroids with little active soma at DIV7, more at DIV14 and very active soma 
at DIV21. 
3.5.6 Disaggregating bio-artificial neurospheroids for single-cell analysis 
Finally, I explored whether cells and devices of bio-artificial hybrid neurospheroids can be 
separated for further single-cell analysis. By using a papain-based tissue dissociation, I found 
that it is possible to disaggregate formed spheroids to collect living single cells separated from 
microchips (Figure 28A). To demonstrate wheather the single cell suspension obtained from 
the disaggregation can be used for further single-cell analysis, I quantified by fluorescence-
activated cell sorting (FACS) the ratio of neurons and glial cells in neurospheroids at DIV28 
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with and without microchips. As shown in Figure 28B, no differences between the two 
conditions was found. On average, spheroids without microchips are composed of 53.1% 
neurons (identified as NeuN+ cells) and 35.4% astrocytes (identified as GFAP+ cells), while 
spheroids with microchips are composed of 51.5% neurons and 39.6% astrocytes (see details 
in Table 2). Thus, beside confirming that the presence of microchips does not alter the spheroid 
cellular composition as previously observed by immunofluorescence analysis, this 
quantification demonstrates the feasibility of single-cell analysis on bio-artificial hybrid 
spheroids.  
 
Figure 28: Single-cell analysis of disaggregated bio-artificial hybrid neurospheroids. A. Schematic 
representation of spheroids disaggregation. Cells and devices of formed bio-artificial hybrid neural 
spheroids were separated and the obtained single cell suspension was analyzed by FACS. B. FACS 
analysis of the ratio of neurons and astrocytes in spheroids without (ctrl, left) and with microchip (right). 
Neurons and astrocytes were labeled with anti-NeuN and anti-GFAP respectively. n=156. 
 
Table 2: FACS analysis after disaggregation of spheroids at DIV28 without (Ctrl) and with microchip. 
Single cells were fixed and stained for neuronal (NeuN) and astrocytic (GFAP) markers. At least 10000 
gated events were analyzed. 
Gated events %Parent Ctrl %Parent µchip
oNeuN+ cells 53.1 51.5
oGFAP+ cells 35.4 39.6
oNeuN+ GFAP+ cells 0.6 0.8
oNeuN- GFAP- cells 8.9 5.8
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3.6 Summary and Perspectives  
Seamlessly tissue-integrated biosensing artificial microdevices can lead to bio-artificial hybrid 
3D brain model systems with built-in biosensors for throughput functional assays. To this aim, 
parallel to the development of an untethered biosensing micro-device, there is the need of better 
understanding how to assemble and grow 3D neural cultures with built-in microscale devices.  
My study focused on the integration of Si microchips into neuronal 3D cell aggregates through 
the assembling of primary cortical cells and microchips, and the growth of hybrid 
neurospheroids over 21 DIVs.  
To do so, I successfully developed a method consisting in the manual seeding of cells and 
microchips, which enables the growth of bio-artificial hybrid neurospheroids with a high yield 
(>78%), although production could be automated and scaled up by using pick-and-place and 
microfluidic techniques. Results show that the presence of Si microchips of 100 x 100 x 50 µm3 
does not affect the developing 3D morphology, cellular composition and the development of 
spontaneous neural activity. Originally, by immobilizing various adhesion-promoting proteins 
on Si microdevices, our results reveal the role of the surface-chemical properties of these 
microchips in driving their assembling with cortical cells and their incorporation inside 
spheroids. In particular, uncoated microchips have poor interaction with cells, matrigel-coated 
microchips remain on the periphery of the spheroid, while PDL- and PDLO-coated microchips 
are integrated inside the spheroid. Finally, I also demonstrated the feasibility of separating cells 
and microchips from formed spheroids for further single-cell analysis. 
Altogether, these findings support the feasibility of realizing a new generation of 3D brain tissue 
models with tissue integrated biosensing microscale devices. Importantly, this work reveals an 
original method to control the spatial integration of micro-devices into cellular constructs. This 
could provide built-in functionalities for routinely monitoring neural activity at sub-millisecond 
resolution and from deeply inside organoids, far behind the performances of currently available 
technologies, or for multiparametric monitoring of other biosignals (e.g. pH, temperature) 
during the growth of organoids or assays.  
Moreover, these results open the possibility of studying the tuning of the surface chemical 
properties of Si microchips to finely control the assembling of 3D bio-artificial neuronal 
constructs with different levels of in-tissue integrated self-standing microdevices. This might 
lead to organoids integrating more than one microdevice, thus enabling to monitor functional 





Figure 29: Findings of the present study open the perspective of integrating multiple, spatially 
controlled micro-scale untethered biosensing devices into organoids for accessing different 
compartments of complex 3D models. 
Controlling the microdevice position in the 3D neural aggregate is particularly relevant for brain 
organoids. For instance, a microdevice with pH sensing capabilities internalized in the center 
of brain organoid would allow routinely monitoring the diffusion of nutrients and oxygen to 
detect the formation of a necrotic core, which in turn would provide crucial information to 
optimize organoid cultures efficiency (Jorfi et al., 2018). Besides, being able to control the 
placement of microdevices at different locations inside organoids would provide access to 
different cellular layers to routinely monitor neural activity or the chemical microenvironment, 
thus overcoming limitations of current imaging techniques for high-throughput read-outs. 
In this work I focused on microscale Si devices having a square area of 100 x 100 µm2 in size 
and 50 µm in thickness that were previously determined from the physical constraints of a RF 
biosensing circuit (Angotzi et al., 2018). However, shape and dimensions of microscale devices 
could provide additional degrees of freedom to tune the device integration inside 3D models 
and need to be evaluated in parallel with CMOS circuit design.  
Future studies need to focus on the assembling of bio-artificial 3D models with human-derived 
neurons, extend the experimental time-window up to over several months and evaluate the 
microdevice performances to establish an efficient built-in-tissue seamless bioelectronic 
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4. Overall Conclusions 
The brain is the most complex and at the same time intriguing human organ. Discovering the 
molecular and cellular mechanisms that regulate its development, as well as understanding 
human brain disorders and their possible causes, and developing new therapeutic approach, are 
just some of the reasons that make the study of the brain so fascinating, attracting the attention 
of many scientists over the centuries and with enormous implications for our society. Despite 
the countless studies carried out and technological advances, many diseases are still incurable.  
A major current limitation is the impossibility of studying the human brain directly across 
molecular, cellular and brain circuit scales. Therefore, there is the need to advance the 
development of adapted brain tissue models.  Current model systems, however, fail in 
mimicking the human brain in all its complexity, with the consequence, for instance, of a poor 
translational relevance of screening results to humans. Developing new technologies and 
achieving biological models that can faithfully reproduce the complex features of human brain 
remains a long-standing challenge.  
In this PhD thesis, I exploited the opportunity of developing new technologies to advance the 
development and application of in vitro brain-on-chip models that enable to address different 
biological questions. 
In the first part, I focused on a microfluidic device developed in our laboratory to 
experimentally investigate the synchronization process of clock genes among distant neuronal 
populations. This original approach allowed to dissect different signaling channels that can not 
be easily addressed in vivo due to the high cellular density and connectivity complexity.  Results 
highlight the presence of at least two pathways for the synchronization of distant and segregated 
neuronal populations: a neuronal paracrine factors-mediated synchronization and an astrocytes-
mediated synchronization. Moreover, results on the study of possible signaling factors suggest 
that paracrine factors-mediated synchronization occurs through a GABA signaling, while 
astrocytes-mediated synchronization requires the involvement of both GABA and glutamate. 
To date, the role of GABA and glutamate, especially in the circadian field, is still not completely 
understood, sometimes controversial and often matter of debate. For the direct astrocyte-to-
neuron synchronization, for example, Barca-Mayo’s study supports a GABA signaling (Barca-
Mayo et al., 2017), while Brancaccio’s one sustains a glutamatergic signaling (Brancaccio et 
al., 2017; Brancaccio et al., 2019). My work supports both visions, with an involvement of both 
GABA and glutamate, but in different contexts. Interestingly, using devices with different 
lengths of the channel, by means different distances between two neuronal populations, I found 
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that the capability of paracrine factors released from a synchronous neuronal population to 
synchronize an asynchronous neuronal population decreases with the increasing of the distance. 
Differently, astrocytes are able to transmit neuronal clock rhythms also at the maximum 
distance tested (17 mm), thus revealing the capacity of astrocytes to act as an active 
communication channel that can synchronize distant neural populations. These results reveal 
that neural populations can be entrained in synchronization through two pathways that could 
imply very different potential roles in brain circuits. Neuronal paracrine factors could be 
involved for local (or short-range) synchronization, while astrocytes can act as active 
communication channels to transfer circadian information to more distant (long-range) neurons. 
Overall, these findings not only highlight the synergic regulation of clock genes among neurons 
and astrocytes, but reinforce the role of astrocytes as active cells in the regulation of clock genes 
in the brain. 
In this direction, during the last period of my PhD I also started to investigate the effects of 
reactive astrocytes, that are astrocytes responding to CNS injury and other neurological 
diseases, on the neuronal circadian rhythms synchronization. Interestingly, preliminary results 
suggest an impairment in the local neuronal synchronization but do not highlight an alteration 
in the propagation of clock rhythms among distant neuronal populations.  
These findings pave the way for the consideration of astrocytes as a new cellular target for 
neuropharmacology of transient or chronic perturbation of circadian rhythms, although further 
analysis will be necessary for a better understanding of the possible link among astrocytes, their 
reactivity, alteration of circadian rhythms and neurodegenerative diseases.  
In the second part of this thesis, I investigated the effects of surface functionalization of Si 
microchips (100 x 100 x 50 µm3) in driving their 3D assembling with cortical cells and in tuning 
their 3D incorporation inside neurospheroids. This work is part of a larger project of my 
laboratory aimed at developing a new generation of “bionic organoids”, that are bio-artificial 
hybrid 3D brain model systems with seamlessly tissue-integrated biosensing microdevices. 
Results show that the presence of Si microchips in neurospheroids does not affect the 
developing 3D morphology, cellular composition and the development of spontaneous neural 
activity. Originally, by immobilizing various adhesion-promoting proteins on Si microdevices, 
results reveal the role of the surface-chemical properties of these microchips in driving their 
assembling with cortical cells and their incorporation inside spheroids.  
Together, these findings support the feasibility of a new generation of 3D brain tissue models 
with tissue integrated biosensing microscale devices. This could provide built-in functionalities 
for routinely monitoring neural activity at sub-millisecond resolution and from deeply inside 
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organoids for behind the performances of currently available technologies, or for 
multiparametric monitoring of other biosignals (e.g. pH, temperature) during 3D model culture 
or assays. Moreover, these results open the possibility of studying the tuning of the surface 
chemical properties of Si microchips to control the assembling of 3D bio-artificial neuronal 
constructs with different levels of in-tissue integrated self-standing microdevices, with the 
possibility to have more than one device in each organoid. Controlling the microdevice position 
in the 3D neural aggregate is particularly relevant for brain organoids. For instance, a 
microdevice with pH sensing capabilities internalized in the center of brain organoid would 
allow routinely monitoring the diffusion of nutrients and oxygen to detect the formation of a 
necrotic core, which in turn would provide crucial information to optimize organoid cultures 
efficiency. Besides, being able to control the placement of microdevices at different locations 
inside organoids would provide access to different cellular layers to routinely monitor neural 
activity or the chemical microenvironment, thus overcoming limitations of current imaging 
techniques for high-throughput read-outs. 
This type of bionic organoid will be a promising model system of the human brain. It can be 
exploit for different applications, such as animal testing replacement for drug discovery and 
screening, personalized medicine, and for brain development, function and dysfunction studies. 
Being a middle between 2D systems and in vivo models, brain organoids can be used to address 
biological questions that, due to the dense cellular connectivity and network complexity, are 
challenging to investigate in vivo.  
Regarding the molecular clock synchronization of distant neuronal populations, for example, a 
fascinating and original perspective is to study in vivo the pathways proposed in this work and 
their implication in health and disease. A strategy could be to focus on the optic nerve as the 
link between the retina and the SCN. If the intercellular communication among optic nerve 
astrocytes is altered, can “time information” pass from the retina to the SCN? 
As it is not easy to use in vivo models to address all circadian questions, 3D aggregates, like 
simple neurospheroids first and more complex brain organoids later, could be a good 
compromise. In this direction I also started to investigate the expression of clock genes in rat 
cortical neurospheroids (Figure 30). In this case, spheroids were maintained in culture for 21 
days and then pulled at different hours of the day for the analysis. Preliminary results show a 
circadian expression of some but not all clock genes. It is important to underline that neurons 
in 2D culture are asynchronous, while astrocytes synchronize by changing medium. This 
suggests that in 3D aggregates, astrocytes, that are always synchronous, can at least start to 
entrain neurons. These findings pave the way for the study of circadian rhythms in 3D brain 
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tissue cultures and might provide a better understanding of mechanisms involved in the 
regulation of molecular clocks as well as their implication in brain diseases. Such understanding 
assumes great relevance in an era in which human beings are increasingly subject to 
dysregulations, mainly caused by the hectic life-style of today’s society.  Altered rhythms of 
our daily life can have a negative impact in short and long term. In the short term, altered 
circadian rhythms interfere with the psycho-physical balance and the consequent efficiency in 
cognitive performance. In the long term, they constitute an important risk factor for health in 
terms of various psychosomatic, gastrointestinal, cardiovascular and neoplastic disorders and 
diseases, which translate into high economic and social costs for individuals and the society. 
Understanding how to intervene on our habits to keep a good regulation of our rhythms can 
definetively help us to improve our quality of life and reduce risks associated with aging. 
 
Figure 30: Clock genes expression in cortical neurospheroids. From left to right, Bmal1, Per2, Dbp 
and Clock expression in rat cortical neurospheroids at DIV21. All genes were analyzed at the indicate 
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the molecular clock synchronization of segregated neural populations: a lab-on-chip 
investigation. 
- Riccitelli S, Boi F, Lonardoni D, Giantomasi L, Barca-Mayo O, De Pietri Tonelli D, 
Bisti S, Di Marco S, Berdondini L. Retinal function is altered by clock gene Bmal1 



















Cortical astrocytes from post-natal rat (P2) 
Materials: 
- Complete medium: DMEM/F-12 (Sigma D6421) supplemented with 1% Glutamax 
(Thermo Fisher Scientific  35050038), 1% Penicillin/Streptomycin (Sigma P4333) and 
10% FBS (Sigma F7524). 
- HBSS: Sigma H6648 
- Digestion solution: Dispase II 2mg/ml (Roche 04942078001) in Phosphate-Buffered 
Saline (PBS) (Thermo Fisher Scientific 10010056) + DNAse I 25µg/ml (Sigma D5025) 
in PBS 
Method:  
Dissection and trypsinization:  
Remove and decapitate pups. 
Remove brains from the skulls and put them in cold HBSS: divide the hemispheres, remove the 
meninges and dissect out the cortex. 
Disaggregate cortices by pipetting with P1000 pipette. 
Place 10 cortices in 20ml of digestion solution and incubate in water bath at 37°C for 30 
minutes.  
Centrifuge for 5 min at 900 rpm.  
Discard supernatant and add fresh complete medium (10ml per pup).  
Dissociate cortex gently by pipetting with 10ml pipette.  
Filter the solution with a cell strainer (from BD, 40µm pore size).  
Plate 10ml per flask (considering 1 flask per pup). 
Changing medium: change completely the medium the day after plating. Then, change 






Cortical neurons from embryonic rat (E18) 
Materials: 
- Complete Neurobasal: Neurobasal medium (Thermo Fisher Scientific 21103049) + 
2% B27 (Thermo Fisher Scientific 17504044) + 1% Glutamax (Thermo Fisher 
Scientific 35050038) + 1% Penicillin/Streptomycin (Sigma P4333) 
- FBS: Sigma F7524 - heat inactivated for 30 min at 56°C 
- HBSS: Sigma H6648 
- Poly-D- lysine in filtered Milli-Q: Sigma P6407 – 0.1 mg/ml 
- Digestion solution: Trypsin 0.125% (Thermo Fisher Scientific 25050014) in HBSS + 
DNAse 0.25 mg/ml (Sigma D5025) in HBSS 5mM CaCl2 
Method:  
Day 1: 
Coating plastic substrates or coverglasses: deposit on each surface a suitable volume of Poly-
D-lysine diluted in Milli-Q water and incubate overnight at 37°C, 5% CO2.  
Day 2: 
Setting of substrates: aspirate poly-D-lysine and wash 3 times with filtered Milli-Q water. 
Dissection and trypsinization:  
Anesthetize and kill pregnant mouse. 
Remove and decapitate embryos. 
Remove brains from the skulls and put them in cold HBSS: divide the hemispheres, remove the 
meninges and dissect out the cortex. 
Place 4 cortices in 5 ml of digestion solution and incubate in water bath at 37°C for 30 minutes.  
After incubation, add to digestion solution few ml of complete Neurobasal + 10% FBS and 
centrifuge for 5 min at 1200 rpm.  
Discard supernatant and add fresh complete Neurobasal + 10% FBS.  
Dissociate cortex gently by pipetting for not more than 10 times with P1000 pipette.  
Filter the solution with a cell strainer (from BD, 40µm pore size).  
Centrifuge for 7 min at 700 rpm, discard supernatant and suspend cells in complete Neurobasal. 
Count cells and plate at the desired density.  
Changing medium: add 50% of medium after 5 days in culture. Then, change 50% of the 
medium every 4-5 days in culture. 
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RNA extraction  
Add 300µl Trizol per sample.  
Place the tube containing the homogenate on the benchtop at room temperature (15–25°C) for 
5 min. 
Add 60µl chloroform. Shake it vigorously for 15 s. 
Incubate at room temperature for 2–3 min. 
Centrifuge at 12000 g for 15 min at 4°C 
Transfer the aqueous phase to a new tube. Add 150µl isopropanol. Mix gently. 
Incubate at room temperature for 10 min. 
Centrifuge at 12000 g for 20 min at 4°C. 
Carefully aspirate and discard the supernatant. 
Add at least 0.5 ml of 75% ethanol. 
Centrifuge at 7500 g for 7 min at 4°C. 
Remove the supernatant completely and briefly air-dry the RNA pellet (5-7 minutes). 
Resuspend the RNA in 18µl RNase-free water. 
 
Treatment with DNase I (Sigma AMPD1): 
Add to an RNase-free PCR tube: 
- 8µl sample containing RNA  
- 1µl 10X Reaction Buffer 
- 1µl DNase I, Amplification Grade 
Mix gently and incubate for 15 minutes at room temperature. 
Add 1µl Stop Solution. 
Heat at 70 °C for 10 minutes. 







Reverse transcription  
Depending on the quantification of RNA, calculate: i) how many µl it is necessary to use in 
order to have a reverse transcription of 300ng of RNA; ii) how many µl of RNase-free water it 
is necessary to add in order to have a final volume of 9µl. 
Material:  
M-MuLV-RH First Strand cDNA Synthesis Kit (Experteam R01-500) 
Method: 
1° step (on ice): 
Add RNase-free water in PCR micro strip 8-tubes. 
Add RNA Sample. 
Add 2µl Random Primers. 
Add 1µl OligodT. 
Place the tubes in the PCR thermal cycler and use the following program: 
- 70 °C  3 min 
- 4 °C  5 min 
In the meantime, prepare the mix for the 2° step:  
- 4µl/sample Buffer 5x 
- 2µl/sample DTT 0.1M 
- 1µl/sample dNTPs 10mM 
- 1µl/ RT enzyme 
2° step (on ice): 
Add 8µl of the mix. 
Place the tubes in the PCR thermal cycler and use the following program: 
- 25 °C  10 min 
- 42 °C  60 min 






Real-time quantitative PCR 
Materials: 
- iTaq Universal SYBR Green Supermix (Biorad 172-5124) 
- Primers: prepare a mix of forward and reverse primers (final concentration 10µM) 
Method: 
Prepare a mix containing 5µl/sample SYBR Green + 0.4µl/sample Primers + 1.6µl/sample 
RNase-free water. 
Add 7µl of the mix in the PCR plate. 
Add 3µl of cDNA sample, previously concentrated 3ng/µl. 
Centrifuge the plate at 1000g 2min. 
Place the plate in the 7900HT Fast Real-Time PCR System and use the following program: 
- 95 °C  30 s 
- 95 °C  15 s 
- 60 °C  60 min 


















Wash 2x with PBS. 
Add 2% PFA + 2% GA for 2h at room temperature. 
Wash 3x with PBS. 
 
Immunostaining: 
Perform all the following steps on a shaker at 4°C. 
Day1: 
Permeabilize and block with Triton X-100 1% + NGS 10% + BSA 4% in PBS (B-PBT) for 2h. 
Incubate with AbI (diluted in B-PBT) overnight. 
Day2: 
Wash 2x (2h) with PBS + Triton X-100 0.2% (PBT). 
Wash 1x (2h) with B-PBT. 
Incubate with AbII (diluted in B-PBT) overnight. 
Day3: 
Wash 2x (2h) with PBT. 
Incubate with Hoechst (diluted 1:300 in PBT) for 1h. 











Calcium imaging (spheroids) 
Materials:  
- Extracellular saline solution: HEPES 10mM + D-Glucose 5.5mM + NaCl 145mM 
+ KCl 5mM + CaCl2 2mM + MgSO4 1mM     pH 7.3-7.4  
- Fluo-4 AM (ThermoFisher 14201) reconstituted in DMSO 
Method: 
Remove medium. 
Incubate with Fluo-4 AM (final concentration of 2.5µg/ml in extracellular saline solution) at 
37°C for 15min. 
Wash 2x with extracellular saline solution. 




















Papain Dissociation System (Worthington Biochemical, LK003150) 
Method:  
Pull spheroids in a tube (one tube per condition). 
Wash with PBS. 
Place in the papain solution (20 units/ml papain, 0.005% DNase). 
Incubate at 37°C in constant agitation (550 rpm). 
Every 10 min, triturate by pipetting with P200 pipette and re-equilibrate the solution with 95% 
O2:5% CO2. 
After 1h, transfer the single cell suspension to a new tube (skip if do not use µdevices). 
Centrifuge at 300g for 5 min at room temperature (RT). 
Resuspend the pelleted cells in albumin-inhibitor solution with DNase. 















Fluorescence-Activated Cell Sorting (FACS) 
Material: 
FACS buffer: 0.05% Triton X-100 + 0.5% BSA in PBS 
Method: 
Fix pelleted cells with PFA 4% for 20 min at room temperature (RT). 
Centrifuge at 1200 rpm for 5 min at RT. 
Permeabilize with Triton X-100 (0.05%) in PBS for 20 min at RT. 
Wash with cold FACS buffer. 
Centrifuge at 1200 rpm for 5 min at RT. 
Incubate with Ab diluted in FACS buffer for 30 min, on ice, in the dark. 
Wash with cold FACS buffer. 
Centrifuge at 1200 rpm for 5 min at RT. 
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